Motif ID: Klf16_Sp8
Z-value: 1.271


Transcription factors associated with Klf16_Sp8:
Gene Symbol | Entrez ID | Gene Name |
---|---|---|
Klf16 | ENSMUSG00000035397.8 | Klf16 |
Sp8 | ENSMUSG00000048562.6 | Sp8 |
Activity-expression correlation:
Gene Symbol | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Sp8 | mm10_v2_chr12_+_118846329_118846329 | 0.59 | 4.3e-05 | Click! |
Klf16 | mm10_v2_chr10_-_80577285_80577327 | -0.27 | 8.3e-02 | Click! |
Top targets:
Gene overrepresentation in biological_process category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.4 | 10.3 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
3.3 | 23.1 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
3.0 | 3.0 | GO:0090194 | negative regulation of glomerular mesangial cell proliferation(GO:0072125) negative regulation of glomerulus development(GO:0090194) |
2.8 | 11.3 | GO:0003360 | brainstem development(GO:0003360) |
2.6 | 12.9 | GO:0007386 | compartment pattern specification(GO:0007386) |
2.4 | 7.3 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
2.3 | 6.8 | GO:0060167 | regulation of adenosine receptor signaling pathway(GO:0060167) |
2.2 | 6.6 | GO:0086047 | membrane depolarization during Purkinje myocyte cell action potential(GO:0086047) |
2.1 | 6.3 | GO:0014738 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
2.0 | 10.2 | GO:0048382 | mesendoderm development(GO:0048382) |
2.0 | 9.8 | GO:0061314 | Notch signaling involved in heart development(GO:0061314) |
1.9 | 11.6 | GO:0072103 | glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
1.9 | 5.6 | GO:1902162 | regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) |
1.8 | 7.3 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
1.8 | 8.9 | GO:0048133 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
1.8 | 5.3 | GO:0030421 | defecation(GO:0030421) |
1.8 | 5.3 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
1.8 | 7.0 | GO:1904457 | positive regulation of neuronal action potential(GO:1904457) |
1.7 | 3.5 | GO:0072197 | ureter morphogenesis(GO:0072197) |
1.7 | 5.2 | GO:0048496 | maintenance of organ identity(GO:0048496) |
1.7 | 5.1 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
1.7 | 5.1 | GO:0061075 | cerebral cortex GABAergic interneuron fate commitment(GO:0021893) positive regulation of neural retina development(GO:0061075) positive regulation of retina development in camera-type eye(GO:1902868) positive regulation of amacrine cell differentiation(GO:1902871) |
1.7 | 5.1 | GO:0061312 | BMP signaling pathway involved in heart development(GO:0061312) |
1.6 | 12.8 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
1.6 | 4.8 | GO:0036166 | phenotypic switching(GO:0036166) |
1.5 | 4.6 | GO:0060166 | olfactory pit development(GO:0060166) |
1.5 | 4.5 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
1.5 | 2.9 | GO:0097350 | neutrophil clearance(GO:0097350) |
1.4 | 2.8 | GO:2000373 | regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000371) positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000373) |
1.4 | 2.8 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
1.4 | 1.4 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
1.4 | 4.1 | GO:0060364 | frontal suture morphogenesis(GO:0060364) |
1.4 | 5.4 | GO:2000705 | regulation of dense core granule biogenesis(GO:2000705) |
1.3 | 1.3 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
1.3 | 5.3 | GO:0015888 | thiamine transport(GO:0015888) |
1.3 | 7.9 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
1.3 | 3.9 | GO:0060598 | dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis(GO:0060598) |
1.3 | 3.9 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
1.3 | 13.1 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
1.3 | 1.3 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
1.3 | 3.9 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
1.3 | 1.3 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
1.3 | 3.8 | GO:1904395 | positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
1.3 | 5.1 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
1.3 | 1.3 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
1.3 | 6.3 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
1.2 | 3.7 | GO:0044837 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
1.2 | 1.2 | GO:0030916 | otic vesicle formation(GO:0030916) |
1.2 | 7.5 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
1.2 | 3.7 | GO:0072382 | minus-end-directed vesicle transport along microtubule(GO:0072382) |
1.2 | 3.7 | GO:0032877 | positive regulation of DNA endoreduplication(GO:0032877) |
1.2 | 4.9 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
1.2 | 3.6 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
1.2 | 4.6 | GO:0031133 | regulation of axon diameter(GO:0031133) |
1.1 | 3.4 | GO:0035604 | fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow(GO:0035602) fibroblast growth factor receptor signaling pathway involved in hemopoiesis(GO:0035603) fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow(GO:0035604) coronal suture morphogenesis(GO:0060365) squamous basal epithelial stem cell differentiation involved in prostate gland acinus development(GO:0060529) |
1.1 | 6.9 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
1.1 | 4.5 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
1.1 | 4.5 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
1.1 | 3.3 | GO:1904975 | response to bleomycin(GO:1904975) cellular response to bleomycin(GO:1904976) |
1.1 | 11.1 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
1.1 | 2.2 | GO:1904020 | regulation of G-protein coupled receptor internalization(GO:1904020) |
1.1 | 6.6 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
1.1 | 3.3 | GO:0010248 | B cell negative selection(GO:0002352) establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
1.1 | 2.2 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
1.1 | 3.2 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
1.1 | 3.2 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
1.1 | 23.3 | GO:0030903 | notochord development(GO:0030903) |
1.1 | 2.1 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
1.1 | 2.1 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
1.0 | 1.0 | GO:1904393 | regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) |
1.0 | 1.0 | GO:0060994 | regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
1.0 | 1.0 | GO:0046545 | development of primary female sexual characteristics(GO:0046545) |
1.0 | 5.1 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
1.0 | 3.1 | GO:0036292 | DNA rewinding(GO:0036292) |
1.0 | 2.0 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
1.0 | 5.1 | GO:0009177 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
1.0 | 5.1 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
1.0 | 4.0 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
1.0 | 3.0 | GO:0045004 | DNA replication proofreading(GO:0045004) |
1.0 | 2.0 | GO:0060591 | chondroblast differentiation(GO:0060591) |
1.0 | 4.0 | GO:0030091 | protein repair(GO:0030091) |
1.0 | 3.0 | GO:0031660 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) |
1.0 | 2.0 | GO:0072191 | ureter smooth muscle development(GO:0072191) ureter smooth muscle cell differentiation(GO:0072193) |
1.0 | 2.9 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
1.0 | 7.9 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
1.0 | 6.8 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
1.0 | 1.0 | GO:0072038 | mesenchymal stem cell maintenance involved in nephron morphogenesis(GO:0072038) |
1.0 | 1.0 | GO:0072223 | metanephric glomerular mesangium development(GO:0072223) metanephric glomerular mesangial cell proliferation involved in metanephros development(GO:0072262) |
1.0 | 1.0 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
0.9 | 4.7 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.9 | 3.8 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
0.9 | 4.7 | GO:0071499 | response to laminar fluid shear stress(GO:0034616) cellular response to laminar fluid shear stress(GO:0071499) |
0.9 | 4.7 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.9 | 2.8 | GO:0061743 | motor learning(GO:0061743) |
0.9 | 0.9 | GO:0036118 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.9 | 1.8 | GO:0035793 | negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) cell migration involved in metanephros development(GO:0035788) metanephric mesenchymal cell migration(GO:0035789) positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) regulation of metanephric mesenchymal cell migration(GO:2000589) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
0.9 | 3.7 | GO:1904565 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
0.9 | 4.5 | GO:0015705 | iodide transport(GO:0015705) |
0.9 | 3.6 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.9 | 1.8 | GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
0.9 | 0.9 | GO:0009757 | carbohydrate mediated signaling(GO:0009756) hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
0.9 | 2.7 | GO:0071707 | immunoglobulin heavy chain V-D-J recombination(GO:0071707) |
0.9 | 2.7 | GO:1902566 | regulation of eosinophil activation(GO:1902566) |
0.9 | 2.7 | GO:1904936 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
0.9 | 2.6 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.9 | 4.4 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
0.9 | 3.5 | GO:0033085 | negative regulation of T cell differentiation in thymus(GO:0033085) |
0.9 | 1.7 | GO:0014009 | glial cell proliferation(GO:0014009) |
0.9 | 3.5 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.9 | 0.9 | GO:1904398 | positive regulation of neuromuscular junction development(GO:1904398) |
0.9 | 7.7 | GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
0.9 | 2.6 | GO:1901355 | response to rapamycin(GO:1901355) |
0.8 | 3.4 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.8 | 5.0 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.8 | 1.7 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.8 | 8.3 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
0.8 | 2.5 | GO:0046655 | glycine biosynthetic process(GO:0006545) folic acid metabolic process(GO:0046655) |
0.8 | 2.5 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.8 | 2.5 | GO:0034184 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.8 | 1.6 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) |
0.8 | 0.8 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.8 | 2.5 | GO:0061642 | chemoattraction of axon(GO:0061642) |
0.8 | 4.1 | GO:0060266 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
0.8 | 1.6 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
0.8 | 2.5 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.8 | 0.8 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.8 | 2.4 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.8 | 15.2 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.8 | 4.8 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.8 | 1.6 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.8 | 1.6 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
0.8 | 2.4 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.8 | 3.1 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.8 | 4.7 | GO:0060923 | cardiac muscle cell fate commitment(GO:0060923) |
0.8 | 18.6 | GO:0048385 | regulation of retinoic acid receptor signaling pathway(GO:0048385) |
0.8 | 2.3 | GO:0021759 | globus pallidus development(GO:0021759) |
0.8 | 7.7 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.8 | 0.8 | GO:0072069 | DCT cell differentiation(GO:0072069) metanephric DCT cell differentiation(GO:0072240) |
0.8 | 3.0 | GO:0032053 | ciliary basal body organization(GO:0032053) |
0.8 | 2.3 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.8 | 0.8 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.7 | 6.7 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.7 | 5.9 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.7 | 1.5 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
0.7 | 8.8 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.7 | 0.7 | GO:0042097 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) |
0.7 | 2.2 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.7 | 5.8 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.7 | 2.2 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.7 | 2.2 | GO:0021553 | olfactory nerve development(GO:0021553) |
0.7 | 3.6 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
0.7 | 1.4 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.7 | 4.3 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.7 | 15.0 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.7 | 5.0 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.7 | 0.7 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
0.7 | 2.1 | GO:0090235 | regulation of metaphase plate congression(GO:0090235) |
0.7 | 3.5 | GO:1901731 | positive regulation of platelet aggregation(GO:1901731) |
0.7 | 0.7 | GO:0031990 | mRNA export from nucleus in response to heat stress(GO:0031990) |
0.7 | 2.1 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.7 | 0.7 | GO:0045137 | development of primary sexual characteristics(GO:0045137) |
0.7 | 0.7 | GO:0043647 | inositol phosphate metabolic process(GO:0043647) |
0.7 | 2.8 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.7 | 0.7 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
0.7 | 3.5 | GO:0006868 | glutamine transport(GO:0006868) |
0.7 | 5.5 | GO:0032776 | DNA methylation on cytosine(GO:0032776) |
0.7 | 4.1 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.7 | 2.7 | GO:0032901 | positive regulation of neurotrophin production(GO:0032901) |
0.7 | 0.7 | GO:0007588 | excretion(GO:0007588) |
0.7 | 7.5 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.7 | 2.0 | GO:0098968 | neurotransmitter receptor transport postsynaptic membrane to endosome(GO:0098968) |
0.7 | 2.7 | GO:0043973 | histone H3-K4 acetylation(GO:0043973) |
0.7 | 4.7 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) |
0.7 | 0.7 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.7 | 6.0 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.7 | 1.3 | GO:0019405 | alditol catabolic process(GO:0019405) |
0.7 | 13.2 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.7 | 2.0 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
0.7 | 20.5 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.7 | 5.9 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.7 | 0.7 | GO:0090272 | negative regulation of fibroblast growth factor production(GO:0090272) |
0.7 | 2.6 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.6 | 7.1 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.6 | 1.9 | GO:0019343 | cysteine biosynthetic process via cystathionine(GO:0019343) cysteine biosynthetic process(GO:0019344) |
0.6 | 1.9 | GO:0048162 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
0.6 | 1.3 | GO:0009814 | defense response, incompatible interaction(GO:0009814) |
0.6 | 0.6 | GO:0002432 | granuloma formation(GO:0002432) |
0.6 | 1.9 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.6 | 3.8 | GO:0048254 | snoRNA localization(GO:0048254) |
0.6 | 2.5 | GO:0072272 | proximal/distal pattern formation involved in metanephric nephron development(GO:0072272) |
0.6 | 0.6 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
0.6 | 3.8 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) |
0.6 | 3.8 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.6 | 3.7 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.6 | 3.1 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.6 | 0.6 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.6 | 6.2 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.6 | 1.2 | GO:0019230 | proprioception(GO:0019230) |
0.6 | 0.6 | GO:0021938 | smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
0.6 | 3.1 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.6 | 1.2 | GO:0033860 | regulation of NAD(P)H oxidase activity(GO:0033860) positive regulation of NAD(P)H oxidase activity(GO:0033864) |
0.6 | 1.9 | GO:0001193 | maintenance of transcriptional fidelity during DNA-templated transcription elongation(GO:0001192) maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter(GO:0001193) |
0.6 | 3.1 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
0.6 | 2.5 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.6 | 1.8 | GO:1901673 | regulation of mitotic spindle assembly(GO:1901673) |
0.6 | 0.6 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) regulation of branch elongation involved in ureteric bud branching(GO:0072095) |
0.6 | 1.8 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.6 | 1.8 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.6 | 0.6 | GO:0033128 | negative regulation of histone phosphorylation(GO:0033128) |
0.6 | 2.4 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.6 | 1.2 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.6 | 4.2 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.6 | 3.5 | GO:0060056 | mammary gland involution(GO:0060056) |
0.6 | 5.8 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.6 | 1.7 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.6 | 2.3 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.6 | 0.6 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.6 | 1.7 | GO:0045819 | plasmacytoid dendritic cell activation(GO:0002270) positive regulation of glycogen catabolic process(GO:0045819) |
0.6 | 0.6 | GO:0061110 | dense core granule biogenesis(GO:0061110) |
0.6 | 1.7 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
0.6 | 2.3 | GO:0060452 | positive regulation of cardiac muscle contraction(GO:0060452) |
0.6 | 0.6 | GO:1904468 | negative regulation of tumor necrosis factor secretion(GO:1904468) |
0.6 | 0.6 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.6 | 3.9 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.6 | 5.6 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.6 | 2.8 | GO:0019659 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.6 | 0.6 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.6 | 4.5 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.6 | 3.3 | GO:0021539 | subthalamus development(GO:0021539) |
0.6 | 1.1 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.6 | 1.1 | GO:0006558 | L-phenylalanine metabolic process(GO:0006558) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) |
0.6 | 1.7 | GO:0046133 | pyrimidine ribonucleoside catabolic process(GO:0046133) |
0.6 | 2.2 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.5 | 3.8 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.5 | 2.2 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.5 | 2.2 | GO:0006409 | tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
0.5 | 1.6 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.5 | 1.6 | GO:0015938 | coenzyme A catabolic process(GO:0015938) nucleoside bisphosphate catabolic process(GO:0033869) ribonucleoside bisphosphate catabolic process(GO:0034031) purine nucleoside bisphosphate catabolic process(GO:0034034) |
0.5 | 2.2 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.5 | 4.8 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.5 | 6.5 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
0.5 | 1.1 | GO:0045950 | negative regulation of mitotic recombination(GO:0045950) |
0.5 | 2.7 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
0.5 | 1.1 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.5 | 3.2 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
0.5 | 4.8 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.5 | 4.3 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.5 | 15.9 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.5 | 3.7 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.5 | 0.5 | GO:0071600 | otic vesicle morphogenesis(GO:0071600) |
0.5 | 1.6 | GO:0019441 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) kynurenine metabolic process(GO:0070189) |
0.5 | 3.2 | GO:0046490 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate metabolic process(GO:0046490) |
0.5 | 4.7 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.5 | 4.2 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.5 | 6.7 | GO:0051451 | myoblast migration(GO:0051451) |
0.5 | 1.0 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.5 | 2.1 | GO:1903504 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
0.5 | 1.5 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.5 | 2.6 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.5 | 5.6 | GO:0070836 | caveola assembly(GO:0070836) |
0.5 | 1.5 | GO:0045799 | positive regulation of chromatin assembly or disassembly(GO:0045799) |
0.5 | 1.5 | GO:0046601 | positive regulation of centriole replication(GO:0046601) |
0.5 | 0.5 | GO:0032911 | transforming growth factor beta1 production(GO:0032905) regulation of transforming growth factor beta1 production(GO:0032908) negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.5 | 5.0 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.5 | 6.5 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.5 | 1.5 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
0.5 | 1.0 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.5 | 1.5 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.5 | 1.0 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.5 | 0.5 | GO:0035993 | deltoid tuberosity development(GO:0035993) |
0.5 | 1.0 | GO:0002725 | negative regulation of T cell cytokine production(GO:0002725) |
0.5 | 1.0 | GO:0007566 | embryo implantation(GO:0007566) |
0.5 | 0.5 | GO:0030859 | polarized epithelial cell differentiation(GO:0030859) |
0.5 | 2.0 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.5 | 2.9 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.5 | 0.5 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.5 | 1.4 | GO:0019236 | response to pheromone(GO:0019236) |
0.5 | 2.4 | GO:0006447 | regulation of translational initiation by iron(GO:0006447) positive regulation of translational initiation by iron(GO:0045994) |
0.5 | 1.0 | GO:0070269 | pyroptosis(GO:0070269) |
0.5 | 0.9 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.5 | 2.4 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.5 | 1.9 | GO:0090035 | regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
0.5 | 1.4 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.5 | 1.4 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.5 | 1.4 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
0.5 | 2.3 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) |
0.5 | 0.9 | GO:1904245 | regulation of polynucleotide adenylyltransferase activity(GO:1904245) |
0.5 | 0.5 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.5 | 1.9 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.5 | 0.5 | GO:1903802 | L-glutamate import across plasma membrane(GO:0098712) L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
0.5 | 10.6 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.5 | 2.8 | GO:0072257 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
0.5 | 0.9 | GO:0072138 | mesenchymal cell proliferation involved in ureteric bud development(GO:0072138) |
0.5 | 2.3 | GO:0003420 | regulation of growth plate cartilage chondrocyte proliferation(GO:0003420) |
0.5 | 1.4 | GO:0071649 | regulation of chemokine (C-C motif) ligand 5 production(GO:0071649) |
0.5 | 1.8 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.5 | 1.4 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.5 | 1.8 | GO:0010836 | negative regulation of protein ADP-ribosylation(GO:0010836) |
0.5 | 0.9 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.5 | 0.5 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
0.5 | 0.9 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.5 | 0.9 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.5 | 1.8 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.4 | 1.8 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.4 | 5.8 | GO:0032461 | positive regulation of protein oligomerization(GO:0032461) |
0.4 | 2.2 | GO:0060068 | vagina development(GO:0060068) |
0.4 | 0.4 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.4 | 0.9 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
0.4 | 2.6 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.4 | 1.3 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
0.4 | 1.7 | GO:0030576 | Cajal body organization(GO:0030576) |
0.4 | 1.3 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.4 | 3.5 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.4 | 1.7 | GO:0051024 | positive regulation of immunoglobulin secretion(GO:0051024) |
0.4 | 10.4 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.4 | 3.5 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.4 | 0.9 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.4 | 1.7 | GO:0021986 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
0.4 | 4.7 | GO:0060539 | diaphragm development(GO:0060539) |
0.4 | 0.4 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.4 | 0.8 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.4 | 1.7 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
0.4 | 1.3 | GO:1903490 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
0.4 | 1.3 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.4 | 0.4 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.4 | 2.1 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.4 | 0.8 | GO:1904751 | positive regulation of protein localization to nucleolus(GO:1904751) |
0.4 | 1.2 | GO:0070315 | G1 to G0 transition involved in cell differentiation(GO:0070315) |
0.4 | 4.5 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.4 | 0.4 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.4 | 2.9 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.4 | 3.7 | GO:1902373 | negative regulation of mRNA catabolic process(GO:1902373) |
0.4 | 1.2 | GO:0061537 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
0.4 | 1.2 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.4 | 1.6 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.4 | 0.8 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.4 | 1.2 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
0.4 | 1.2 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.4 | 0.8 | GO:0010171 | body morphogenesis(GO:0010171) |
0.4 | 0.4 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.4 | 2.0 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.4 | 1.6 | GO:0014005 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
0.4 | 1.2 | GO:0051026 | chiasma assembly(GO:0051026) |
0.4 | 0.8 | GO:2001204 | regulation of osteoclast development(GO:2001204) |
0.4 | 4.8 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.4 | 1.2 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.4 | 2.8 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.4 | 0.4 | GO:0043586 | tongue development(GO:0043586) |
0.4 | 1.6 | GO:0032627 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) |
0.4 | 0.8 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.4 | 5.4 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.4 | 1.9 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
0.4 | 15.4 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.4 | 1.2 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
0.4 | 0.8 | GO:1903998 | regulation of eating behavior(GO:1903998) |
0.4 | 1.1 | GO:0006547 | histidine metabolic process(GO:0006547) |
0.4 | 2.3 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.4 | 1.1 | GO:0086053 | AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
0.4 | 3.4 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.4 | 3.0 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.4 | 1.5 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
0.4 | 2.2 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.4 | 2.2 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.4 | 1.1 | GO:0010814 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
0.4 | 1.1 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.4 | 1.1 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.4 | 1.8 | GO:0000454 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
0.4 | 2.2 | GO:0045583 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.4 | 1.1 | GO:0030647 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.4 | 0.4 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.4 | 0.7 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.4 | 1.1 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.4 | 0.7 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.4 | 1.1 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.4 | 3.9 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.4 | 1.1 | GO:0071105 | response to interleukin-11(GO:0071105) |
0.4 | 0.4 | GO:0016332 | establishment or maintenance of polarity of embryonic epithelium(GO:0016332) |
0.4 | 1.1 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) |
0.4 | 1.1 | GO:0034473 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
0.4 | 1.8 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.4 | 2.1 | GO:0006108 | malate metabolic process(GO:0006108) |
0.4 | 1.1 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
0.4 | 1.1 | GO:0019323 | pentose catabolic process(GO:0019323) |
0.4 | 1.4 | GO:0015744 | succinate transport(GO:0015744) |
0.3 | 0.3 | GO:0090259 | regulation of retinal ganglion cell axon guidance(GO:0090259) |
0.3 | 7.3 | GO:0035036 | binding of sperm to zona pellucida(GO:0007339) sperm-egg recognition(GO:0035036) |
0.3 | 1.4 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
0.3 | 1.7 | GO:0031424 | keratinization(GO:0031424) |
0.3 | 0.7 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) |
0.3 | 1.0 | GO:0032493 | response to bacterial lipoprotein(GO:0032493) |
0.3 | 1.7 | GO:1902302 | regulation of potassium ion export(GO:1902302) |
0.3 | 1.0 | GO:0034241 | positive regulation of macrophage fusion(GO:0034241) |
0.3 | 1.0 | GO:1905077 | negative regulation of interleukin-17 secretion(GO:1905077) |
0.3 | 0.3 | GO:0060850 | regulation of transcription involved in cell fate commitment(GO:0060850) |
0.3 | 0.7 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.3 | 0.7 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.3 | 2.4 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.3 | 1.0 | GO:0019043 | establishment of viral latency(GO:0019043) |
0.3 | 3.0 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
0.3 | 2.0 | GO:0007144 | female meiosis I(GO:0007144) |
0.3 | 0.7 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.3 | 1.0 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
0.3 | 1.6 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.3 | 2.3 | GO:0097501 | stress response to metal ion(GO:0097501) |
0.3 | 5.3 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.3 | 0.3 | GO:0051036 | regulation of endosome size(GO:0051036) |
0.3 | 1.3 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.3 | 1.0 | GO:0098869 | cellular oxidant detoxification(GO:0098869) |
0.3 | 1.0 | GO:0000492 | box C/D snoRNP assembly(GO:0000492) |
0.3 | 4.8 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.3 | 1.6 | GO:0040031 | snRNA modification(GO:0040031) |
0.3 | 4.8 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.3 | 0.6 | GO:0010958 | regulation of amino acid import(GO:0010958) |
0.3 | 0.3 | GO:0007520 | myoblast fusion(GO:0007520) |
0.3 | 2.9 | GO:0060179 | male mating behavior(GO:0060179) |
0.3 | 0.6 | GO:0061357 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) positive regulation of Wnt protein secretion(GO:0061357) |
0.3 | 0.6 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.3 | 1.3 | GO:0030202 | heparin metabolic process(GO:0030202) |
0.3 | 2.5 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.3 | 1.3 | GO:0006570 | tyrosine metabolic process(GO:0006570) |
0.3 | 1.3 | GO:0035624 | receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
0.3 | 1.3 | GO:1903298 | regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) |
0.3 | 1.6 | GO:0072675 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
0.3 | 9.4 | GO:0006284 | base-excision repair(GO:0006284) |
0.3 | 0.9 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
0.3 | 0.3 | GO:1903719 | regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
0.3 | 0.9 | GO:0086028 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.3 | 5.6 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.3 | 0.6 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.3 | 1.2 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.3 | 0.6 | GO:0000237 | leptotene(GO:0000237) |
0.3 | 0.6 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
0.3 | 3.1 | GO:0006337 | nucleosome disassembly(GO:0006337) |
0.3 | 1.8 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.3 | 0.3 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) |
0.3 | 1.5 | GO:0006271 | DNA strand elongation involved in DNA replication(GO:0006271) |
0.3 | 5.8 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
0.3 | 0.9 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.3 | 0.9 | GO:1903976 | negative regulation of glial cell migration(GO:1903976) |
0.3 | 2.7 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
0.3 | 0.6 | GO:0060857 | establishment of glial blood-brain barrier(GO:0060857) |
0.3 | 1.5 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.3 | 4.2 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
0.3 | 3.3 | GO:0031639 | plasminogen activation(GO:0031639) |
0.3 | 1.8 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.3 | 6.0 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.3 | 1.8 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.3 | 0.3 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.3 | 1.5 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
0.3 | 3.8 | GO:0071451 | cellular response to oxygen radical(GO:0071450) cellular response to superoxide(GO:0071451) |
0.3 | 2.6 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.3 | 1.2 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
0.3 | 0.3 | GO:2001160 | regulation of histone H3-K79 methylation(GO:2001160) |
0.3 | 0.9 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.3 | 0.6 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.3 | 1.5 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.3 | 1.2 | GO:0015889 | cobalamin transport(GO:0015889) |
0.3 | 0.9 | GO:0046061 | dATP catabolic process(GO:0046061) |
0.3 | 0.3 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
0.3 | 0.6 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
0.3 | 1.7 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.3 | 0.9 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.3 | 3.7 | GO:0003334 | keratinocyte development(GO:0003334) |
0.3 | 1.1 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) cellular response to lipid hydroperoxide(GO:0071449) |
0.3 | 0.6 | GO:0010871 | negative regulation of receptor biosynthetic process(GO:0010871) |
0.3 | 1.1 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.3 | 0.3 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
0.3 | 5.0 | GO:0033260 | nuclear DNA replication(GO:0033260) |
0.3 | 1.9 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.3 | 3.6 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.3 | 0.3 | GO:0014016 | neuroblast differentiation(GO:0014016) |
0.3 | 14.1 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.3 | 0.6 | GO:0090237 | regulation of arachidonic acid secretion(GO:0090237) positive regulation of arachidonic acid secretion(GO:0090238) |
0.3 | 1.6 | GO:0032782 | bile acid secretion(GO:0032782) |
0.3 | 0.3 | GO:0001978 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) |
0.3 | 0.8 | GO:0009414 | response to water deprivation(GO:0009414) |
0.3 | 1.9 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.3 | 1.6 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.3 | 0.8 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.3 | 2.2 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.3 | 1.1 | GO:0051295 | establishment of meiotic spindle localization(GO:0051295) |
0.3 | 0.5 | GO:1901526 | positive regulation of macromitophagy(GO:1901526) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
0.3 | 1.9 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.3 | 0.5 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.3 | 0.8 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.3 | 4.6 | GO:0000338 | protein deneddylation(GO:0000338) |
0.3 | 1.9 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.3 | 0.8 | GO:0031204 | posttranslational protein targeting to membrane, translocation(GO:0031204) |
0.3 | 0.3 | GO:0033084 | regulation of immature T cell proliferation in thymus(GO:0033084) positive regulation of immature T cell proliferation(GO:0033091) positive regulation of immature T cell proliferation in thymus(GO:0033092) |
0.3 | 1.1 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.3 | 0.8 | GO:0001755 | neural crest cell migration(GO:0001755) |
0.3 | 0.5 | GO:0072282 | metanephric nephron tubule morphogenesis(GO:0072282) |
0.3 | 0.8 | GO:0072081 | proximal/distal pattern formation involved in nephron development(GO:0072047) specification of nephron tubule identity(GO:0072081) specification of loop of Henle identity(GO:0072086) |
0.3 | 0.5 | GO:0034331 | cell junction maintenance(GO:0034331) |
0.3 | 0.5 | GO:0098914 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
0.3 | 1.0 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.3 | 0.3 | GO:0051023 | regulation of immunoglobulin secretion(GO:0051023) |
0.3 | 5.4 | GO:0048255 | mRNA stabilization(GO:0048255) |
0.3 | 1.3 | GO:0007320 | insemination(GO:0007320) |
0.3 | 0.5 | GO:0046689 | response to mercury ion(GO:0046689) |
0.3 | 2.3 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.3 | 2.0 | GO:0035437 | maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.3 | 0.5 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.3 | 0.5 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.3 | 0.8 | GO:0070476 | rRNA (guanine-N7)-methylation(GO:0070476) |
0.3 | 1.0 | GO:0046909 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
0.3 | 1.0 | GO:0002553 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.3 | 0.5 | GO:0006477 | protein sulfation(GO:0006477) |
0.3 | 0.3 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
0.2 | 4.2 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.2 | 1.0 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.2 | 1.2 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.2 | 1.5 | GO:1901911 | diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
0.2 | 1.5 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.2 | 2.2 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.2 | 2.2 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.2 | 0.7 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.2 | 0.5 | GO:0009204 | deoxyribonucleoside triphosphate catabolic process(GO:0009204) |
0.2 | 1.0 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.2 | 0.7 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.2 | 1.2 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.2 | 0.5 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
0.2 | 0.2 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.2 | 2.1 | GO:1901409 | positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.2 | 1.2 | GO:0052428 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.2 | 2.6 | GO:0021889 | olfactory bulb interneuron differentiation(GO:0021889) |
0.2 | 1.4 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.2 | 0.7 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
0.2 | 0.7 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.2 | 1.9 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.2 | 0.9 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.2 | 1.2 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.2 | 0.9 | GO:0009068 | aspartate family amino acid catabolic process(GO:0009068) |
0.2 | 0.7 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.2 | 2.3 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.2 | 1.8 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.2 | 3.9 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.2 | 2.3 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
0.2 | 1.1 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.2 | 0.7 | GO:1904046 | negative regulation of vascular endothelial growth factor production(GO:1904046) |
0.2 | 1.1 | GO:2000425 | regulation of apoptotic cell clearance(GO:2000425) |
0.2 | 2.0 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
0.2 | 1.3 | GO:0060026 | convergent extension(GO:0060026) |
0.2 | 0.9 | GO:0070858 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.2 | 0.9 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.2 | 3.3 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.2 | 0.2 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.2 | 0.7 | GO:1903048 | regulation of acetylcholine-gated cation channel activity(GO:1903048) |
0.2 | 0.2 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.2 | 0.2 | GO:0034392 | negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
0.2 | 2.8 | GO:0043486 | histone exchange(GO:0043486) |
0.2 | 1.1 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.2 | 0.2 | GO:0071316 | cellular response to nicotine(GO:0071316) |
0.2 | 1.1 | GO:0010636 | positive regulation of mitochondrial fusion(GO:0010636) |
0.2 | 2.8 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.2 | 0.9 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.2 | 0.9 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.2 | 0.2 | GO:0071474 | cellular hyperosmotic response(GO:0071474) |
0.2 | 3.4 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.2 | 0.4 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.2 | 0.6 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.2 | 0.2 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) |
0.2 | 1.1 | GO:0021910 | smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021910) |
0.2 | 0.4 | GO:1901970 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
0.2 | 0.8 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.2 | 2.1 | GO:0001675 | acrosome assembly(GO:0001675) |
0.2 | 0.4 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
0.2 | 0.6 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
0.2 | 0.2 | GO:0072615 | interleukin-17 secretion(GO:0072615) |
0.2 | 1.0 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.2 | 0.8 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.2 | 0.2 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.2 | 0.4 | GO:0072610 | interleukin-12 secretion(GO:0072610) regulation of interleukin-12 secretion(GO:2001182) positive regulation of interleukin-12 secretion(GO:2001184) |
0.2 | 0.4 | GO:0032536 | regulation of microvillus length(GO:0032532) regulation of cell projection size(GO:0032536) |
0.2 | 0.2 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
0.2 | 1.4 | GO:0043201 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.2 | 0.8 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.2 | 0.4 | GO:0035989 | tendon development(GO:0035989) |
0.2 | 0.4 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
0.2 | 3.0 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.2 | 0.4 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.2 | 1.4 | GO:0032310 | prostaglandin secretion(GO:0032310) |
0.2 | 1.2 | GO:0032459 | regulation of protein oligomerization(GO:0032459) |
0.2 | 1.2 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.2 | 2.6 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.2 | 0.6 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.2 | 0.4 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.2 | 0.6 | GO:2000105 | positive regulation of DNA-dependent DNA replication(GO:2000105) |
0.2 | 0.6 | GO:1903630 | regulation of aminoacyl-tRNA ligase activity(GO:1903630) positive regulation of aminoacyl-tRNA ligase activity(GO:1903632) regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
0.2 | 0.6 | GO:1902031 | regulation of pentose-phosphate shunt(GO:0043456) regulation of NADP metabolic process(GO:1902031) |
0.2 | 1.6 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.2 | 0.6 | GO:0001980 | regulation of systemic arterial blood pressure by ischemic conditions(GO:0001980) |
0.2 | 0.8 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.2 | 0.2 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.2 | 0.2 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.2 | 0.8 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.2 | 0.2 | GO:0046902 | regulation of mitochondrial membrane permeability(GO:0046902) regulation of membrane permeability(GO:0090559) |
0.2 | 0.6 | GO:0045601 | regulation of endothelial cell differentiation(GO:0045601) |
0.2 | 3.7 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.2 | 1.0 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.2 | 0.8 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.2 | 0.2 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) |
0.2 | 2.5 | GO:0051299 | centrosome separation(GO:0051299) |
0.2 | 1.2 | GO:0046459 | short-chain fatty acid metabolic process(GO:0046459) |
0.2 | 0.4 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.2 | 0.4 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.2 | 0.2 | GO:0072203 | cell proliferation involved in metanephros development(GO:0072203) |
0.2 | 1.0 | GO:0018002 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.2 | 0.6 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.2 | 1.7 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.2 | 1.5 | GO:0042167 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.2 | 0.6 | GO:1904207 | chemokine (C-C motif) ligand 2 secretion(GO:0035926) regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
0.2 | 0.2 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
0.2 | 0.4 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.2 | 0.6 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.2 | 0.6 | GO:0002940 | tRNA N2-guanine methylation(GO:0002940) |
0.2 | 0.9 | GO:0045669 | positive regulation of osteoblast differentiation(GO:0045669) |
0.2 | 0.9 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.2 | 1.5 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.2 | 1.7 | GO:1903541 | regulation of exosomal secretion(GO:1903541) positive regulation of exosomal secretion(GO:1903543) |
0.2 | 1.3 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.2 | 0.6 | GO:1901628 | positive regulation of postsynaptic membrane organization(GO:1901628) positive regulation of receptor clustering(GO:1903911) |
0.2 | 0.4 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.2 | 2.6 | GO:0043248 | proteasome assembly(GO:0043248) |
0.2 | 1.1 | GO:0001711 | endodermal cell fate commitment(GO:0001711) |
0.2 | 0.2 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.2 | 1.7 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.2 | 0.4 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.2 | 0.5 | GO:0001180 | transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
0.2 | 0.2 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.2 | 2.4 | GO:0042407 | cristae formation(GO:0042407) |
0.2 | 0.7 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.2 | 0.5 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
0.2 | 0.5 | GO:0051030 | snRNA transport(GO:0051030) |
0.2 | 1.3 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.2 | 0.7 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.2 | 0.2 | GO:0010259 | multicellular organism aging(GO:0010259) |
0.2 | 1.6 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.2 | 0.5 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
0.2 | 2.5 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.2 | 1.3 | GO:0006534 | cysteine metabolic process(GO:0006534) |
0.2 | 4.1 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.2 | 2.1 | GO:0035115 | embryonic forelimb morphogenesis(GO:0035115) |
0.2 | 2.8 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.2 | 1.1 | GO:0044241 | lipid digestion(GO:0044241) |
0.2 | 0.4 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
0.2 | 1.1 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.2 | 1.6 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
0.2 | 0.2 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.2 | 0.5 | GO:0098974 | postsynaptic actin cytoskeleton organization(GO:0098974) |
0.2 | 1.2 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
0.2 | 2.1 | GO:0046697 | decidualization(GO:0046697) |
0.2 | 0.9 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
0.2 | 2.1 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.2 | 1.0 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.2 | 0.7 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.2 | 1.4 | GO:0048484 | enteric nervous system development(GO:0048484) |
0.2 | 0.7 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.2 | 2.2 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.2 | 0.7 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.2 | 0.2 | GO:0010870 | positive regulation of receptor biosynthetic process(GO:0010870) |
0.2 | 0.5 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
0.2 | 1.7 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.2 | 0.5 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.2 | 0.3 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
0.2 | 0.3 | GO:0060192 | negative regulation of lipase activity(GO:0060192) |
0.2 | 0.3 | GO:0002339 | B cell selection(GO:0002339) |
0.2 | 0.3 | GO:1990859 | cellular response to endothelin(GO:1990859) |
0.2 | 1.5 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.2 | 0.5 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.2 | 0.5 | GO:0043383 | negative T cell selection(GO:0043383) negative thymic T cell selection(GO:0045060) |
0.2 | 0.7 | GO:0001842 | neural fold formation(GO:0001842) |
0.2 | 0.3 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.2 | 3.1 | GO:0035067 | negative regulation of histone acetylation(GO:0035067) |
0.2 | 2.4 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) |
0.2 | 0.3 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.2 | 4.2 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
0.2 | 1.9 | GO:0097201 | negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
0.2 | 1.8 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.2 | 1.3 | GO:0090042 | tubulin deacetylation(GO:0090042) |
0.2 | 0.3 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
0.2 | 0.3 | GO:0036302 | atrioventricular canal development(GO:0036302) |
0.2 | 0.3 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.2 | 1.1 | GO:0006968 | cellular defense response(GO:0006968) |
0.2 | 1.1 | GO:0090205 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
0.2 | 1.6 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.2 | 0.3 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.2 | 0.6 | GO:0046368 | GDP-L-fucose metabolic process(GO:0046368) |
0.2 | 0.6 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) |
0.2 | 0.2 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
0.2 | 0.6 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.2 | 0.8 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.2 | 0.8 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.2 | 0.5 | GO:0015793 | glycerol transport(GO:0015793) |
0.2 | 0.5 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.2 | 0.5 | GO:0097152 | mesenchymal cell apoptotic process(GO:0097152) |
0.2 | 2.1 | GO:0033194 | response to hydroperoxide(GO:0033194) |
0.2 | 2.4 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.2 | 1.4 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.2 | 4.1 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.2 | 0.3 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.2 | 1.4 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
0.1 | 0.3 | GO:1904690 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.1 | 0.4 | GO:0072139 | glomerular parietal epithelial cell differentiation(GO:0072139) positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) positive regulation of nephron tubule epithelial cell differentiation(GO:2000768) |
0.1 | 0.1 | GO:0072044 | collecting duct development(GO:0072044) |
0.1 | 0.3 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.1 | 0.1 | GO:0070459 | prolactin secretion(GO:0070459) |
0.1 | 0.1 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.1 | 0.9 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.1 | 0.7 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.1 | 0.6 | GO:0070301 | cellular response to hydrogen peroxide(GO:0070301) |
0.1 | 0.3 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
0.1 | 0.9 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.1 | 0.4 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
0.1 | 1.0 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.1 | 0.1 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.1 | 0.1 | GO:1902932 | positive regulation of alcohol biosynthetic process(GO:1902932) |
0.1 | 0.9 | GO:0051307 | meiotic chromosome separation(GO:0051307) |
0.1 | 0.7 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.1 | 1.3 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.1 | 1.7 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
0.1 | 0.6 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 1.0 | GO:0030261 | chromosome condensation(GO:0030261) |
0.1 | 1.0 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
0.1 | 2.3 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.1 | 1.6 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.1 | 1.3 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.1 | 0.7 | GO:0051697 | protein delipidation(GO:0051697) |
0.1 | 0.3 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.1 | 1.1 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.1 | 1.0 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.1 | 1.4 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.1 | 0.6 | GO:0050812 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.1 | 0.8 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.1 | 1.0 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.1 | 0.7 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.1 | 2.2 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.1 | 1.7 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.1 | 0.3 | GO:0072283 | metanephric renal vesicle morphogenesis(GO:0072283) |
0.1 | 0.4 | GO:0042823 | pyridoxal phosphate biosynthetic process(GO:0042823) |
0.1 | 0.4 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.1 | 0.5 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.1 | 0.1 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
0.1 | 0.5 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.1 | 1.5 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.1 | 0.4 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
0.1 | 0.4 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.1 | 1.1 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.1 | 0.1 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
0.1 | 0.4 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.1 | 0.5 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.1 | 1.2 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.1 | 0.1 | GO:0072087 | renal vesicle development(GO:0072087) |
0.1 | 0.3 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.1 | 0.4 | GO:2000858 | mineralocorticoid secretion(GO:0035931) aldosterone secretion(GO:0035932) regulation of mineralocorticoid secretion(GO:2000855) positive regulation of mineralocorticoid secretion(GO:2000857) regulation of aldosterone secretion(GO:2000858) positive regulation of aldosterone secretion(GO:2000860) |
0.1 | 0.6 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.1 | 0.4 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.1 | 0.1 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
0.1 | 0.3 | GO:0031497 | chromatin assembly(GO:0031497) |
0.1 | 1.3 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.1 | 1.6 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.1 | 0.1 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
0.1 | 0.5 | GO:0048286 | lung alveolus development(GO:0048286) |
0.1 | 0.4 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.1 | 0.6 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.1 | 0.1 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
0.1 | 1.1 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.1 | 1.1 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.1 | 0.2 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.1 | 5.2 | GO:0006414 | translational elongation(GO:0006414) |
0.1 | 0.5 | GO:0042730 | fibrinolysis(GO:0042730) |
0.1 | 0.4 | GO:0090103 | cochlea morphogenesis(GO:0090103) |
0.1 | 0.8 | GO:0043649 | dicarboxylic acid catabolic process(GO:0043649) |
0.1 | 0.1 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.1 | 0.6 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.1 | 0.2 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.1 | 0.7 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.1 | 0.1 | GO:0030852 | regulation of granulocyte differentiation(GO:0030852) |
0.1 | 1.0 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
0.1 | 0.3 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) |
0.1 | 0.3 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.1 | 0.7 | GO:0070193 | synaptonemal complex organization(GO:0070193) |
0.1 | 0.5 | GO:0021780 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
0.1 | 0.6 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.1 | 0.8 | GO:2000191 | regulation of fatty acid transport(GO:2000191) |
0.1 | 1.0 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.1 | 0.5 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.1 | 0.1 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.1 | 0.2 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
0.1 | 0.1 | GO:0072718 | response to cisplatin(GO:0072718) |
0.1 | 0.5 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) |
0.1 | 0.3 | GO:0000429 | carbon catabolite regulation of transcription from RNA polymerase II promoter(GO:0000429) regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) carbon catabolite activation of transcription from RNA polymerase II promoter(GO:0000436) carbon catabolite regulation of transcription(GO:0045990) carbon catabolite activation of transcription(GO:0045991) positive regulation of transcription by glucose(GO:0046016) |
0.1 | 1.2 | GO:0014823 | response to activity(GO:0014823) |
0.1 | 0.2 | GO:0032423 | regulation of mismatch repair(GO:0032423) |
0.1 | 0.1 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.1 | 2.1 | GO:0030901 | midbrain development(GO:0030901) |
0.1 | 0.3 | GO:0051933 | amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) |
0.1 | 0.2 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.1 | 1.1 | GO:0032060 | bleb assembly(GO:0032060) |
0.1 | 3.3 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.1 | 0.4 | GO:0007094 | mitotic spindle assembly checkpoint(GO:0007094) spindle assembly checkpoint(GO:0071173) |
0.1 | 0.1 | GO:0051305 | meiotic chromosome movement towards spindle pole(GO:0016344) chromosome movement towards spindle pole(GO:0051305) |
0.1 | 1.3 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.1 | 0.9 | GO:0015865 | purine nucleotide transport(GO:0015865) |
0.1 | 1.4 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
0.1 | 0.5 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.1 | 0.3 | GO:1904578 | response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) |
0.1 | 1.2 | GO:0010574 | regulation of vascular endothelial growth factor production(GO:0010574) |
0.1 | 0.1 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.1 | 0.6 | GO:1902751 | positive regulation of cell cycle G2/M phase transition(GO:1902751) |
0.1 | 0.1 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.1 | 0.4 | GO:1902608 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.1 | 4.0 | GO:0034605 | cellular response to heat(GO:0034605) |
0.1 | 2.1 | GO:0003301 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.1 | 0.4 | GO:1904994 | regulation of leukocyte adhesion to vascular endothelial cell(GO:1904994) |
0.1 | 0.6 | GO:0001996 | regulation of systemic arterial blood pressure by norepinephrine-epinephrine(GO:0001993) positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) regulation of heart rate by chemical signal(GO:0003062) positive regulation of heart rate by epinephrine(GO:0003065) positive regulation of blood pressure by epinephrine-norepinephrine(GO:0003321) |
0.1 | 0.3 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.1 | 0.7 | GO:1990748 | cellular detoxification(GO:1990748) |
0.1 | 0.4 | GO:0051189 | molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.1 | 0.8 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.1 | 0.5 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.1 | 0.1 | GO:2000825 | positive regulation of androgen receptor activity(GO:2000825) |
0.1 | 0.7 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.1 | 1.0 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.1 | 0.3 | GO:0042275 | error-free postreplication DNA repair(GO:0042275) |
0.1 | 0.6 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.1 | 0.1 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.1 | 0.2 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.1 | 3.8 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.1 | 0.2 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.1 | 0.7 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.1 | 1.0 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.1 | 0.2 | GO:1990839 | response to endothelin(GO:1990839) |
0.1 | 1.5 | GO:2001244 | positive regulation of intrinsic apoptotic signaling pathway(GO:2001244) |
0.1 | 0.1 | GO:0003177 | pulmonary valve development(GO:0003177) pulmonary valve morphogenesis(GO:0003184) |
0.1 | 4.8 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.1 | 2.2 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.1 | 0.4 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.1 | 0.6 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.1 | 0.4 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.1 | 0.4 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.1 | 1.3 | GO:0050684 | regulation of mRNA processing(GO:0050684) |
0.1 | 3.9 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.1 | 1.3 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.1 | 0.4 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.1 | 0.8 | GO:0006754 | ATP biosynthetic process(GO:0006754) |
0.1 | 0.1 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) |
0.1 | 0.3 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.1 | 0.2 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
0.1 | 1.0 | GO:0008637 | apoptotic mitochondrial changes(GO:0008637) |
0.1 | 0.3 | GO:0017185 | peptidyl-lysine hydroxylation(GO:0017185) |
0.1 | 0.2 | GO:0002385 | organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
0.1 | 0.2 | GO:0060025 | regulation of synaptic activity(GO:0060025) |
0.1 | 0.3 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.1 | 1.2 | GO:0043488 | regulation of mRNA stability(GO:0043488) |
0.1 | 0.5 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.1 | 0.1 | GO:0035089 | establishment of apical/basal cell polarity(GO:0035089) |
0.1 | 0.3 | GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.1 | 0.1 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.1 | 0.1 | GO:1902730 | positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.1 | 3.3 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.1 | 0.1 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 1.0 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.1 | 2.4 | GO:0042168 | heme metabolic process(GO:0042168) |
0.1 | 0.3 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.1 | 0.3 | GO:0046666 | retinal cell programmed cell death(GO:0046666) |
0.1 | 0.1 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.1 | 0.5 | GO:0034142 | toll-like receptor 4 signaling pathway(GO:0034142) |
0.1 | 0.1 | GO:0002578 | negative regulation of antigen processing and presentation(GO:0002578) |
0.1 | 0.1 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.1 | 0.4 | GO:0060334 | regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.1 | 1.4 | GO:0007614 | short-term memory(GO:0007614) |
0.1 | 0.6 | GO:0032722 | positive regulation of chemokine production(GO:0032722) |
0.1 | 0.4 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.1 | 0.3 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
0.1 | 0.2 | GO:1900025 | negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
0.1 | 1.2 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.1 | 0.1 | GO:0019401 | alditol biosynthetic process(GO:0019401) |
0.1 | 0.3 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.1 | 0.2 | GO:1902807 | negative regulation of cell cycle G1/S phase transition(GO:1902807) |
0.1 | 0.2 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.1 | 0.5 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.1 | 0.2 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
0.1 | 0.8 | GO:0031297 | replication fork processing(GO:0031297) |
0.1 | 0.5 | GO:0002011 | morphogenesis of an epithelial sheet(GO:0002011) |
0.1 | 0.2 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
0.1 | 0.5 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.1 | 0.3 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.1 | 2.7 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
0.1 | 1.1 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
0.1 | 0.2 | GO:0051353 | positive regulation of oxidoreductase activity(GO:0051353) |
0.1 | 0.6 | GO:0001709 | cell fate determination(GO:0001709) |
0.1 | 3.6 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.1 | 0.2 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.1 | 0.2 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.1 | 0.4 | GO:0002467 | germinal center formation(GO:0002467) |
0.1 | 0.4 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.1 | 0.2 | GO:0046381 | CMP-N-acetylneuraminate metabolic process(GO:0046381) |
0.1 | 1.0 | GO:0006907 | pinocytosis(GO:0006907) |
0.1 | 0.2 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.1 | 0.2 | GO:0007006 | mitochondrial membrane organization(GO:0007006) |
0.1 | 0.1 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
0.1 | 0.1 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.1 | 0.4 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.1 | 0.8 | GO:0006366 | transcription from RNA polymerase II promoter(GO:0006366) |
0.1 | 0.2 | GO:0043489 | RNA stabilization(GO:0043489) |
0.1 | 2.3 | GO:0071230 | cellular response to amino acid stimulus(GO:0071230) |
0.1 | 0.2 | GO:1901072 | glucosamine-containing compound catabolic process(GO:1901072) |
0.1 | 0.4 | GO:1901998 | toxin transport(GO:1901998) |
0.1 | 0.1 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.1 | 4.5 | GO:0008033 | tRNA processing(GO:0008033) |
0.1 | 0.2 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.1 | 0.1 | GO:2001046 | positive regulation of integrin-mediated signaling pathway(GO:2001046) |
0.1 | 0.2 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
0.1 | 1.3 | GO:0051225 | spindle assembly(GO:0051225) |
0.1 | 0.3 | GO:0009109 | coenzyme catabolic process(GO:0009109) |
0.1 | 0.3 | GO:0034214 | protein hexamerization(GO:0034214) |
0.1 | 2.2 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.1 | 1.4 | GO:0042775 | mitochondrial ATP synthesis coupled electron transport(GO:0042775) |
0.1 | 0.4 | GO:0043616 | keratinocyte proliferation(GO:0043616) |
0.1 | 0.5 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.1 | 0.2 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.1 | 0.2 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.1 | 0.2 | GO:0050892 | intestinal absorption(GO:0050892) |
0.1 | 3.0 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.1 | 0.5 | GO:0044786 | cell cycle DNA replication(GO:0044786) |
0.1 | 0.1 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.1 | 1.1 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.1 | 0.1 | GO:1990523 | bone regeneration(GO:1990523) |
0.1 | 1.3 | GO:0044319 | wound healing, spreading of cells(GO:0044319) epiboly involved in wound healing(GO:0090505) |
0.1 | 0.1 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.1 | 0.4 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.1 | 1.5 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.1 | 0.2 | GO:1903961 | positive regulation of anion transmembrane transport(GO:1903961) |
0.1 | 1.1 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.1 | 2.3 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.1 | 0.1 | GO:0045989 | positive regulation of striated muscle contraction(GO:0045989) |
0.1 | 1.2 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.1 | 0.2 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.1 | 0.7 | GO:0009303 | rRNA transcription(GO:0009303) |
0.1 | 0.2 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.1 | 0.1 | GO:1900673 | olefin metabolic process(GO:1900673) |
0.1 | 0.1 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.1 | 0.1 | GO:0043633 | polyadenylation-dependent RNA catabolic process(GO:0043633) polyadenylation-dependent ncRNA catabolic process(GO:0043634) |
0.1 | 0.6 | GO:0050687 | negative regulation of defense response to virus(GO:0050687) |
0.1 | 0.1 | GO:0046166 | glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
0.1 | 0.3 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.1 | 0.2 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.1 | 0.8 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.1 | 1.1 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.1 | 0.3 | GO:1903755 | regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
0.1 | 0.2 | GO:0000737 | DNA catabolic process, endonucleolytic(GO:0000737) |
0.1 | 1.6 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.1 | 0.1 | GO:0032609 | interferon-gamma production(GO:0032609) |
0.1 | 0.1 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.1 | 0.4 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.1 | 0.3 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 0.1 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.1 | 0.9 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 0.1 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.1 | 0.4 | GO:0098700 | neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.1 | 0.5 | GO:0005980 | polysaccharide catabolic process(GO:0000272) glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.1 | 0.2 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.1 | 0.7 | GO:0090307 | mitotic spindle assembly(GO:0090307) |
0.1 | 0.1 | GO:2000744 | anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
0.1 | 0.1 | GO:0035729 | cellular response to hepatocyte growth factor stimulus(GO:0035729) |
0.1 | 0.3 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.1 | 0.3 | GO:0051461 | regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
0.1 | 1.0 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.1 | 0.1 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.1 | 0.2 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.1 | 0.9 | GO:0031397 | negative regulation of protein ubiquitination(GO:0031397) |
0.0 | 0.0 | GO:0034287 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.0 | 1.3 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.0 | 0.2 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.0 | 1.0 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.0 | 0.4 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.0 | 0.0 | GO:0090500 | endocardial cushion to mesenchymal transition(GO:0090500) |
0.0 | 0.0 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.0 | 0.0 | GO:0046051 | UTP metabolic process(GO:0046051) |
0.0 | 0.2 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.0 | 0.4 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.0 | 0.5 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.0 | 0.5 | GO:0030575 | nuclear body organization(GO:0030575) |
0.0 | 1.2 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.0 | 0.2 | GO:0006953 | acute-phase response(GO:0006953) |
0.0 | 0.1 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.0 | 0.5 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
0.0 | 0.3 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.0 | 0.2 | GO:2001022 | positive regulation of response to DNA damage stimulus(GO:2001022) |
0.0 | 0.2 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.0 | 0.2 | GO:2000194 | regulation of female gonad development(GO:2000194) |
0.0 | 1.0 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.0 | 0.2 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.0 | 0.2 | GO:0033140 | negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
0.0 | 0.1 | GO:0032332 | positive regulation of chondrocyte differentiation(GO:0032332) |
0.0 | 0.1 | GO:0030825 | positive regulation of cGMP metabolic process(GO:0030825) positive regulation of cGMP biosynthetic process(GO:0030828) |
0.0 | 0.9 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.0 | 0.1 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
0.0 | 0.1 | GO:0060706 | cell differentiation involved in embryonic placenta development(GO:0060706) |
0.0 | 11.4 | GO:0008380 | RNA splicing(GO:0008380) |
0.0 | 0.3 | GO:0048875 | chemical homeostasis within a tissue(GO:0048875) |
0.0 | 0.1 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.0 | 0.1 | GO:1904407 | positive regulation of nitric oxide biosynthetic process(GO:0045429) positive regulation of nitric oxide metabolic process(GO:1904407) |
0.0 | 0.1 | GO:0006586 | tryptophan metabolic process(GO:0006568) indolalkylamine metabolic process(GO:0006586) |
0.0 | 0.1 | GO:0098886 | modification of dendritic spine(GO:0098886) |
0.0 | 0.5 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.0 | 0.2 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.0 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) |
0.0 | 0.1 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.0 | 0.3 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
0.0 | 0.2 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.0 | 0.1 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.0 | 0.0 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.0 | 0.0 | GO:0010511 | regulation of phosphatidylinositol biosynthetic process(GO:0010511) |
0.0 | 0.4 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
0.0 | 0.2 | GO:0008105 | asymmetric protein localization(GO:0008105) |
0.0 | 0.3 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.0 | 0.1 | GO:0002374 | cytokine secretion involved in immune response(GO:0002374) |
0.0 | 0.3 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.0 | 0.2 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.0 | 0.3 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.0 | 0.3 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.0 | 0.2 | GO:0090049 | regulation of cell migration involved in sprouting angiogenesis(GO:0090049) |
0.0 | 0.2 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.0 | 0.1 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.0 | 0.0 | GO:0046476 | glycosylceramide biosynthetic process(GO:0046476) |
0.0 | 0.2 | GO:0002534 | cytokine production involved in inflammatory response(GO:0002534) regulation of cytokine production involved in inflammatory response(GO:1900015) |
0.0 | 0.1 | GO:0006312 | mitotic recombination(GO:0006312) |
0.0 | 0.5 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.0 | 0.1 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
0.0 | 1.5 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.0 | 0.0 | GO:0032366 | intracellular sterol transport(GO:0032366) intracellular cholesterol transport(GO:0032367) |
0.0 | 0.1 | GO:0061217 | positive regulation of mesonephros development(GO:0061213) regulation of mesonephros development(GO:0061217) |
0.0 | 0.1 | GO:0030856 | regulation of epithelial cell differentiation(GO:0030856) |
0.0 | 0.3 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.0 | 0.3 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
0.0 | 0.0 | GO:0060441 | epithelial tube branching involved in lung morphogenesis(GO:0060441) |
0.0 | 0.0 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.0 | 0.1 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.0 | 0.0 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
0.0 | 0.1 | GO:0036065 | fucosylation(GO:0036065) |
0.0 | 0.0 | GO:0002923 | regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002923) |
0.0 | 0.3 | GO:0006301 | postreplication repair(GO:0006301) |
0.0 | 0.2 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.0 | 0.1 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.0 | 0.1 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.0 | 0.0 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.0 | 0.1 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.0 | 0.0 | GO:0098534 | centriole replication(GO:0007099) centriole assembly(GO:0098534) |
0.0 | 0.2 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
0.0 | 0.1 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.0 | 0.1 | GO:0018195 | peptidyl-arginine modification(GO:0018195) |
0.0 | 0.4 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.0 | 0.6 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.0 | 0.0 | GO:0032506 | cytokinetic process(GO:0032506) |
0.0 | 0.1 | GO:1990022 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
0.0 | 0.0 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.0 | 0.0 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.0 | 0.0 | GO:0003192 | mitral valve formation(GO:0003192) condensed mesenchymal cell proliferation(GO:0072137) |
0.0 | 0.1 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.0 | 0.3 | GO:0001824 | blastocyst development(GO:0001824) |
0.0 | 0.0 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) regulation of endoribonuclease activity(GO:0060699) negative regulation of ribonuclease activity(GO:0060701) negative regulation of endoribonuclease activity(GO:0060702) |
0.0 | 0.4 | GO:0071482 | cellular response to light stimulus(GO:0071482) |
0.0 | 0.1 | GO:0030043 | actin filament fragmentation(GO:0030043) |
0.0 | 0.1 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.0 | 0.1 | GO:0006415 | translational termination(GO:0006415) |
0.0 | 0.0 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.0 | 0.3 | GO:0001825 | blastocyst formation(GO:0001825) |
0.0 | 0.1 | GO:0060761 | negative regulation of response to cytokine stimulus(GO:0060761) |
0.0 | 0.0 | GO:0032757 | positive regulation of interleukin-8 production(GO:0032757) |
0.0 | 0.1 | GO:0033622 | integrin activation(GO:0033622) |
0.0 | 4.4 | GO:0006412 | translation(GO:0006412) |
0.0 | 0.0 | GO:0061744 | motor behavior(GO:0061744) |
0.0 | 0.1 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.0 | 0.1 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.0 | 0.0 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.0 | 0.0 | GO:0038061 | NIK/NF-kappaB signaling(GO:0038061) |
0.0 | 0.1 | GO:1902224 | cellular ketone body metabolic process(GO:0046950) ketone body metabolic process(GO:1902224) |
0.0 | 0.2 | GO:2000573 | positive regulation of DNA biosynthetic process(GO:2000573) |
0.0 | 0.1 | GO:1903232 | melanosome assembly(GO:1903232) |
0.0 | 0.1 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
0.0 | 0.1 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
0.0 | 0.0 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.0 | 0.3 | GO:0016925 | protein sumoylation(GO:0016925) |
0.0 | 0.1 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.0 | 0.0 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.0 | 0.0 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.0 | 0.1 | GO:0048864 | stem cell development(GO:0048864) |
0.0 | 0.2 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
Gene overrepresentation in cellular_component category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.8 | 11.3 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
3.2 | 9.6 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
2.3 | 11.3 | GO:0032133 | chromosome passenger complex(GO:0032133) |
1.7 | 11.7 | GO:0042627 | chylomicron(GO:0042627) |
1.6 | 3.3 | GO:0042585 | germinal vesicle(GO:0042585) |
1.6 | 14.6 | GO:0000796 | condensin complex(GO:0000796) |
1.5 | 4.5 | GO:0031680 | G-protein beta/gamma-subunit complex(GO:0031680) |
1.4 | 8.2 | GO:0031262 | Ndc80 complex(GO:0031262) |
1.3 | 3.9 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
1.2 | 3.7 | GO:0033186 | CAF-1 complex(GO:0033186) |
1.2 | 5.8 | GO:0097149 | centralspindlin complex(GO:0097149) |
1.1 | 3.4 | GO:0005577 | fibrinogen complex(GO:0005577) |
1.1 | 5.4 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
1.1 | 6.5 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
1.0 | 1.0 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
1.0 | 6.0 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
1.0 | 3.9 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.9 | 2.8 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.9 | 6.1 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.8 | 6.8 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.8 | 2.5 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.8 | 5.8 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.8 | 4.1 | GO:0005861 | troponin complex(GO:0005861) |
0.8 | 4.9 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.8 | 3.2 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.8 | 5.5 | GO:0008278 | cohesin complex(GO:0008278) |
0.8 | 2.3 | GO:0035061 | interchromatin granule(GO:0035061) |
0.7 | 4.5 | GO:0097452 | GAIT complex(GO:0097452) |
0.7 | 2.2 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.7 | 8.1 | GO:0005642 | annulate lamellae(GO:0005642) |
0.7 | 2.9 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.7 | 2.2 | GO:0045298 | tubulin complex(GO:0045298) |
0.7 | 2.2 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.7 | 5.7 | GO:0070652 | HAUS complex(GO:0070652) |
0.7 | 4.2 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.7 | 2.1 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.7 | 2.0 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.7 | 4.0 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.7 | 3.9 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.6 | 0.6 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.6 | 5.8 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.6 | 3.8 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.6 | 4.4 | GO:0001740 | Barr body(GO:0001740) |
0.6 | 5.6 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.6 | 8.1 | GO:0030057 | desmosome(GO:0030057) |
0.6 | 4.3 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.6 | 1.2 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.6 | 2.4 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.6 | 1.8 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.6 | 7.4 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.6 | 3.4 | GO:0034448 | EGO complex(GO:0034448) |
0.6 | 2.3 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
0.6 | 4.5 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.5 | 2.7 | GO:0070938 | contractile ring(GO:0070938) |
0.5 | 5.3 | GO:0016580 | Sin3 complex(GO:0016580) |
0.5 | 3.7 | GO:0005657 | replication fork(GO:0005657) |
0.5 | 6.4 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.5 | 29.3 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.5 | 5.7 | GO:0005915 | zonula adherens(GO:0005915) |
0.5 | 5.6 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.5 | 1.5 | GO:0033193 | Lsd1/2 complex(GO:0033193) |
0.5 | 1.5 | GO:0035101 | FACT complex(GO:0035101) |
0.5 | 7.1 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.5 | 6.5 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.5 | 2.5 | GO:0097226 | sperm mitochondrial sheath(GO:0097226) |
0.5 | 12.9 | GO:0001741 | XY body(GO:0001741) |
0.5 | 8.7 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.5 | 4.8 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.5 | 0.5 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.5 | 7.1 | GO:0031011 | Ino80 complex(GO:0031011) |
0.5 | 1.4 | GO:0000939 | condensed chromosome inner kinetochore(GO:0000939) |
0.5 | 1.8 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.5 | 5.0 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.5 | 4.5 | GO:0010369 | chromocenter(GO:0010369) |
0.4 | 1.8 | GO:0032021 | NELF complex(GO:0032021) |
0.4 | 0.9 | GO:0043224 | nuclear SCF ubiquitin ligase complex(GO:0043224) |
0.4 | 4.8 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.4 | 2.6 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.4 | 0.4 | GO:0005605 | basal lamina(GO:0005605) |
0.4 | 1.3 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
0.4 | 2.5 | GO:0070852 | cell body fiber(GO:0070852) |
0.4 | 2.1 | GO:0044301 | climbing fiber(GO:0044301) |
0.4 | 2.0 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.4 | 3.6 | GO:0001939 | female pronucleus(GO:0001939) |
0.4 | 2.8 | GO:0097422 | tubular endosome(GO:0097422) |
0.4 | 4.8 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.4 | 1.6 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.4 | 1.2 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.4 | 1.2 | GO:0034684 | integrin alphav-beta5 complex(GO:0034684) |
0.4 | 28.4 | GO:0005844 | polysome(GO:0005844) |
0.4 | 2.7 | GO:0072687 | meiotic spindle(GO:0072687) |
0.4 | 0.4 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.4 | 4.9 | GO:0046930 | pore complex(GO:0046930) |
0.4 | 2.2 | GO:0035976 | AP1 complex(GO:0035976) |
0.4 | 3.3 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.4 | 3.3 | GO:0089701 | U2AF(GO:0089701) |
0.4 | 7.8 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.4 | 8.8 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.4 | 1.4 | GO:0071942 | XPC complex(GO:0071942) |
0.3 | 1.4 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.3 | 1.7 | GO:0016589 | NURF complex(GO:0016589) |
0.3 | 16.2 | GO:0005876 | spindle microtubule(GO:0005876) |
0.3 | 2.1 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.3 | 4.5 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.3 | 2.7 | GO:0016600 | flotillin complex(GO:0016600) |
0.3 | 1.7 | GO:0045179 | apical cortex(GO:0045179) |
0.3 | 2.7 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.3 | 3.3 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) |
0.3 | 1.0 | GO:0043073 | germ cell nucleus(GO:0043073) |
0.3 | 2.6 | GO:0090543 | Flemming body(GO:0090543) |
0.3 | 3.5 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.3 | 1.0 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.3 | 1.3 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.3 | 2.8 | GO:0045120 | pronucleus(GO:0045120) |
0.3 | 1.2 | GO:0045283 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.3 | 1.5 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.3 | 1.5 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.3 | 2.1 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.3 | 1.5 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.3 | 4.7 | GO:0071564 | npBAF complex(GO:0071564) |
0.3 | 1.2 | GO:0031523 | Myb complex(GO:0031523) |
0.3 | 3.5 | GO:0097542 | ciliary tip(GO:0097542) |
0.3 | 0.6 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.3 | 1.2 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
0.3 | 2.6 | GO:0061617 | MICOS complex(GO:0061617) |
0.3 | 4.2 | GO:0031528 | microvillus membrane(GO:0031528) |
0.3 | 5.4 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.3 | 0.6 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.3 | 3.9 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.3 | 8.4 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.3 | 1.1 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.3 | 5.0 | GO:0043218 | compact myelin(GO:0043218) |
0.3 | 1.7 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.3 | 2.2 | GO:0042382 | paraspeckles(GO:0042382) |
0.3 | 1.9 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.3 | 0.8 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
0.3 | 0.5 | GO:0005685 | U1 snRNP(GO:0005685) |
0.3 | 1.6 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.3 | 0.8 | GO:0005940 | septin ring(GO:0005940) |
0.3 | 2.1 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.3 | 1.6 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.3 | 10.1 | GO:0000791 | euchromatin(GO:0000791) |
0.3 | 3.4 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.3 | 1.3 | GO:1990357 | terminal web(GO:1990357) |
0.3 | 16.2 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.3 | 1.0 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.3 | 1.0 | GO:0045171 | intercellular bridge(GO:0045171) |
0.2 | 1.7 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.2 | 1.0 | GO:1990590 | ATF1-ATF4 transcription factor complex(GO:1990590) |
0.2 | 0.2 | GO:0036452 | ESCRT I complex(GO:0000813) ESCRT complex(GO:0036452) |
0.2 | 0.7 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
0.2 | 1.9 | GO:0097427 | microtubule bundle(GO:0097427) |
0.2 | 2.3 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.2 | 1.2 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.2 | 0.9 | GO:0002111 | BRCA2-BRAF35 complex(GO:0002111) |
0.2 | 4.3 | GO:0030914 | STAGA complex(GO:0030914) |
0.2 | 2.2 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.2 | 0.4 | GO:0001652 | granular component(GO:0001652) |
0.2 | 1.1 | GO:0099524 | region of cytosol(GO:0099522) postsynaptic cytosol(GO:0099524) |
0.2 | 3.6 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.2 | 1.1 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.2 | 0.7 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.2 | 2.8 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.2 | 1.3 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.2 | 0.4 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.2 | 3.3 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.2 | 1.2 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.2 | 1.6 | GO:0031415 | NatA complex(GO:0031415) |
0.2 | 4.1 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.2 | 0.8 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.2 | 1.0 | GO:0005688 | U6 snRNP(GO:0005688) |
0.2 | 0.4 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.2 | 1.0 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.2 | 0.4 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
0.2 | 2.0 | GO:0000800 | lateral element(GO:0000800) |
0.2 | 2.5 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.2 | 0.6 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.2 | 17.8 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.2 | 2.3 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.2 | 1.5 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.2 | 1.5 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.2 | 6.2 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.2 | 0.9 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.2 | 12.6 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.2 | 0.2 | GO:0044299 | C-fiber(GO:0044299) |
0.2 | 0.5 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.2 | 10.3 | GO:0015934 | large ribosomal subunit(GO:0015934) |
0.2 | 2.3 | GO:0032156 | septin cytoskeleton(GO:0032156) |
0.2 | 2.6 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.2 | 2.1 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.2 | 0.5 | GO:0005673 | transcription factor TFIIE complex(GO:0005673) |
0.2 | 1.2 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.2 | 1.2 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.2 | 8.1 | GO:0022626 | cytosolic ribosome(GO:0022626) |
0.2 | 9.9 | GO:0005581 | collagen trimer(GO:0005581) |
0.2 | 1.5 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.2 | 1.8 | GO:0045095 | keratin filament(GO:0045095) |
0.2 | 0.2 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.2 | 0.2 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.2 | 1.4 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.2 | 54.6 | GO:0005667 | transcription factor complex(GO:0005667) |
0.2 | 0.5 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) |
0.2 | 1.4 | GO:0016272 | prefoldin complex(GO:0016272) |
0.2 | 1.1 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.1 | 0.4 | GO:0071914 | prominosome(GO:0071914) |
0.1 | 3.0 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.1 | 2.2 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.1 | 0.6 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.1 | 0.4 | GO:0043540 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex(GO:0043540) |
0.1 | 0.7 | GO:0072487 | MSL complex(GO:0072487) |
0.1 | 0.6 | GO:0097574 | lateral part of cell(GO:0097574) basolateral part of cell(GO:1990794) rod bipolar cell terminal bouton(GO:1990795) |
0.1 | 1.3 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.1 | 0.1 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
0.1 | 0.3 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
0.1 | 2.0 | GO:0043034 | costamere(GO:0043034) |
0.1 | 1.9 | GO:0005858 | axonemal dynein complex(GO:0005858) |
0.1 | 0.4 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.1 | 0.7 | GO:0060293 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.1 | 2.2 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 0.7 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.1 | 1.9 | GO:0005652 | nuclear lamina(GO:0005652) |
0.1 | 0.3 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.1 | 0.7 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.1 | 0.5 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.1 | 1.6 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 3.2 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.1 | 0.4 | GO:0033391 | chromatoid body(GO:0033391) |
0.1 | 0.4 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.1 | 1.8 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.1 | 1.4 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.1 | 0.5 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
0.1 | 0.6 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.1 | 0.5 | GO:0097651 | phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
0.1 | 1.1 | GO:0043189 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.1 | 1.0 | GO:0016460 | myosin II complex(GO:0016460) |
0.1 | 6.0 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.1 | 3.7 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.1 | 0.1 | GO:0031430 | M band(GO:0031430) |
0.1 | 5.9 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.1 | 33.0 | GO:0016607 | nuclear speck(GO:0016607) |
0.1 | 0.5 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.1 | 3.2 | GO:0005840 | ribosome(GO:0005840) |
0.1 | 1.7 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.1 | 0.8 | GO:0060091 | kinocilium(GO:0060091) |
0.1 | 6.5 | GO:0070469 | respiratory chain(GO:0070469) |
0.1 | 0.3 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
0.1 | 3.3 | GO:0005871 | kinesin complex(GO:0005871) |
0.1 | 0.9 | GO:0034719 | SMN complex(GO:0032797) SMN-Sm protein complex(GO:0034719) |
0.1 | 1.8 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.1 | 5.1 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.1 | 5.0 | GO:0000793 | condensed chromosome(GO:0000793) |
0.1 | 0.5 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 2.8 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 2.0 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 0.8 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.1 | 0.1 | GO:0070876 | SOSS complex(GO:0070876) |
0.1 | 0.7 | GO:0002177 | manchette(GO:0002177) |
0.1 | 0.2 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.1 | 1.3 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 0.6 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 0.3 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
0.1 | 1.4 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 2.7 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.1 | 5.7 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.1 | 1.1 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.1 | 0.4 | GO:0000974 | Prp19 complex(GO:0000974) |
0.1 | 2.6 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.1 | 0.7 | GO:0030056 | hemidesmosome(GO:0030056) |
0.1 | 0.5 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 7.2 | GO:0005814 | centriole(GO:0005814) |
0.1 | 9.2 | GO:0000776 | kinetochore(GO:0000776) |
0.1 | 0.9 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.1 | 2.5 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.1 | 1.9 | GO:0030686 | 90S preribosome(GO:0030686) |
0.1 | 0.2 | GO:1990246 | uniplex complex(GO:1990246) |
0.1 | 1.1 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.1 | 3.5 | GO:0032420 | stereocilium(GO:0032420) |
0.1 | 0.6 | GO:0097546 | ciliary base(GO:0097546) |
0.1 | 17.9 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 4.3 | GO:0072562 | blood microparticle(GO:0072562) |
0.1 | 0.7 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
0.1 | 1.3 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 0.5 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.1 | 3.2 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
0.1 | 2.5 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 0.2 | GO:0070069 | cytochrome complex(GO:0070069) |
0.1 | 0.1 | GO:1902737 | dendritic filopodium(GO:1902737) |
0.1 | 0.4 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.2 | GO:0031372 | UBC13-MMS2 complex(GO:0031372) |
0.1 | 0.5 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 0.2 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 14.2 | GO:0000785 | chromatin(GO:0000785) |
0.1 | 0.4 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 0.3 | GO:0034709 | methylosome(GO:0034709) |
0.1 | 0.9 | GO:0005839 | proteasome core complex(GO:0005839) |
0.1 | 0.8 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 0.2 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) cytoplasmic side of late endosome membrane(GO:0098560) |
0.1 | 0.8 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 1.3 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 2.0 | GO:0002102 | podosome(GO:0002102) |
0.1 | 2.3 | GO:0005902 | microvillus(GO:0005902) |
0.1 | 6.9 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.1 | 1.1 | GO:0015030 | Cajal body(GO:0015030) |
0.1 | 0.5 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.1 | 0.1 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.1 | 0.8 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.1 | 0.4 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.1 | 0.2 | GO:0072534 | perineuronal net(GO:0072534) |
0.1 | 0.1 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.1 | 0.6 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 0.5 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.1 | 0.3 | GO:1990356 | sumoylated E2 ligase complex(GO:1990356) |
0.1 | 0.1 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.1 | 0.2 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.1 | 0.6 | GO:0031527 | filopodium membrane(GO:0031527) |
0.1 | 0.1 | GO:0097444 | spine apparatus(GO:0097444) |
0.1 | 2.9 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.1 | 0.4 | GO:0042581 | specific granule(GO:0042581) |
0.1 | 2.1 | GO:0036126 | sperm flagellum(GO:0036126) |
0.1 | 0.8 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 0.2 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.1 | 0.4 | GO:0043657 | host(GO:0018995) host cell part(GO:0033643) host cell(GO:0043657) other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.1 | 0.7 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.0 | 0.2 | GO:0097361 | CIA complex(GO:0097361) |
0.0 | 0.1 | GO:0098842 | postsynaptic early endosome(GO:0098842) |
0.0 | 0.2 | GO:0005883 | neurofilament(GO:0005883) |
0.0 | 0.4 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.0 | 1.8 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 0.6 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.0 | 0.1 | GO:0097233 | lamellar body membrane(GO:0097232) alveolar lamellar body membrane(GO:0097233) |
0.0 | 0.7 | GO:0031514 | motile cilium(GO:0031514) |
0.0 | 0.1 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
0.0 | 0.1 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.0 | 0.3 | GO:0051286 | cell tip(GO:0051286) |
0.0 | 0.0 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.0 | 4.3 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.0 | 0.4 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.0 | 0.1 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) TAP complex(GO:0042825) |
0.0 | 0.0 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
0.0 | 0.8 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 0.2 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.0 | 0.4 | GO:0032040 | small-subunit processome(GO:0032040) |
0.0 | 0.1 | GO:0031012 | extracellular matrix(GO:0031012) |
0.0 | 0.1 | GO:1990415 | Pex17p-Pex14p docking complex(GO:1990415) peroxisomal importomer complex(GO:1990429) |
0.0 | 0.1 | GO:0008623 | CHRAC(GO:0008623) |
0.0 | 0.2 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.0 | 0.1 | GO:0061702 | inflammasome complex(GO:0061702) |
0.0 | 6.2 | GO:0005813 | centrosome(GO:0005813) |
0.0 | 0.0 | GO:0097255 | R2TP complex(GO:0097255) |
0.0 | 1.2 | GO:0044291 | cell-cell contact zone(GO:0044291) |
0.0 | 16.9 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 0.1 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.0 | 0.0 | GO:0034464 | BBSome(GO:0034464) |
0.0 | 0.2 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 0.2 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.0 | 0.0 | GO:0061574 | ASAP complex(GO:0061574) |
0.0 | 0.0 | GO:0018444 | translation release factor complex(GO:0018444) |
0.0 | 0.2 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.0 | 0.0 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.0 | 0.3 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.0 | 0.1 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.0 | 0.2 | GO:0030904 | retromer complex(GO:0030904) |
Gene overrepresentation in molecular_function category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.7 | 8.0 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
2.5 | 12.5 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
2.4 | 7.1 | GO:0035939 | microsatellite binding(GO:0035939) |
2.2 | 10.9 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
2.0 | 9.9 | GO:0032027 | myosin light chain binding(GO:0032027) |
1.9 | 11.4 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
1.8 | 5.5 | GO:0070052 | collagen V binding(GO:0070052) |
1.8 | 7.0 | GO:0003844 | 1,4-alpha-glucan branching enzyme activity(GO:0003844) |
1.7 | 5.2 | GO:0015403 | thiamine uptake transmembrane transporter activity(GO:0015403) |
1.7 | 9.9 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
1.6 | 6.4 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
1.6 | 7.9 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
1.6 | 14.1 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
1.5 | 4.5 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
1.3 | 6.6 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
1.2 | 3.6 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
1.2 | 6.0 | GO:0042289 | MHC class II protein binding(GO:0042289) |
1.2 | 2.3 | GO:0004921 | interleukin-11 receptor activity(GO:0004921) interleukin-11 binding(GO:0019970) |
1.1 | 4.5 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
1.1 | 4.5 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
1.1 | 3.3 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
1.1 | 15.1 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
1.1 | 7.5 | GO:0034056 | estrogen response element binding(GO:0034056) |
1.0 | 3.0 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
1.0 | 1.0 | GO:0015616 | DNA translocase activity(GO:0015616) |
1.0 | 2.9 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
1.0 | 3.9 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
1.0 | 3.8 | GO:1990254 | keratin filament binding(GO:1990254) |
0.9 | 3.8 | GO:0031687 | A2A adenosine receptor binding(GO:0031687) |
0.9 | 3.6 | GO:0042806 | fucose binding(GO:0042806) |
0.9 | 2.7 | GO:0071207 | histone pre-mRNA stem-loop binding(GO:0071207) |
0.9 | 12.5 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.9 | 3.6 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.9 | 2.7 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
0.9 | 0.9 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.9 | 3.5 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.9 | 1.7 | GO:1990405 | protein antigen binding(GO:1990405) |
0.9 | 2.6 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.8 | 1.7 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.8 | 4.2 | GO:0052833 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.8 | 4.1 | GO:0031014 | troponin T binding(GO:0031014) |
0.8 | 2.5 | GO:0051870 | methotrexate binding(GO:0051870) |
0.8 | 2.4 | GO:0033680 | ATP-dependent DNA/RNA helicase activity(GO:0033680) |
0.8 | 10.4 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.8 | 5.6 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.8 | 5.6 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
0.8 | 3.2 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
0.8 | 5.5 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.8 | 3.1 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.8 | 3.9 | GO:0043515 | kinetochore binding(GO:0043515) |
0.7 | 2.9 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.7 | 1.5 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.7 | 3.7 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
0.7 | 4.4 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.7 | 5.8 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.7 | 3.6 | GO:0005534 | galactose binding(GO:0005534) |
0.7 | 2.1 | GO:0030156 | benzodiazepine receptor binding(GO:0030156) |
0.7 | 2.8 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.7 | 2.1 | GO:0004962 | endothelin receptor activity(GO:0004962) |
0.7 | 2.1 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.7 | 1.4 | GO:0034046 | poly(G) binding(GO:0034046) |
0.7 | 4.2 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.7 | 2.8 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
0.7 | 2.8 | GO:0086038 | calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential(GO:0086038) |
0.7 | 4.2 | GO:0043426 | MRF binding(GO:0043426) |
0.7 | 2.8 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
0.7 | 11.0 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.7 | 2.1 | GO:0070140 | isopeptidase activity(GO:0070122) ubiquitin-like protein-specific isopeptidase activity(GO:0070138) SUMO-specific isopeptidase activity(GO:0070140) |
0.7 | 4.0 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.7 | 0.7 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) |
0.7 | 2.0 | GO:0030629 | U6 snRNA 3'-end binding(GO:0030629) |
0.7 | 8.5 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.7 | 7.2 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.7 | 20.2 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.6 | 0.6 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
0.6 | 0.6 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.6 | 1.2 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) |
0.6 | 3.7 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.6 | 2.5 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.6 | 13.9 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.6 | 3.6 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.6 | 9.6 | GO:0003680 | AT DNA binding(GO:0003680) |
0.6 | 4.2 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.6 | 10.0 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.6 | 4.1 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.6 | 22.9 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.6 | 1.7 | GO:0000402 | open form four-way junction DNA binding(GO:0000401) crossed form four-way junction DNA binding(GO:0000402) |
0.6 | 3.9 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.6 | 3.4 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.6 | 1.7 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.6 | 3.3 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.6 | 9.4 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.5 | 2.2 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.5 | 4.8 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.5 | 2.1 | GO:0008142 | oxysterol binding(GO:0008142) |
0.5 | 1.6 | GO:0036132 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
0.5 | 2.1 | GO:2001069 | glycogen binding(GO:2001069) |
0.5 | 9.0 | GO:0035198 | miRNA binding(GO:0035198) |
0.5 | 3.7 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.5 | 1.0 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.5 | 1.6 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
0.5 | 4.1 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.5 | 6.2 | GO:0031996 | thioesterase binding(GO:0031996) |
0.5 | 2.0 | GO:0038049 | glucocorticoid receptor activity(GO:0004883) transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
0.5 | 3.6 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.5 | 2.5 | GO:0038132 | neuregulin binding(GO:0038132) |
0.5 | 6.1 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.5 | 3.0 | GO:0008494 | translation activator activity(GO:0008494) |
0.5 | 2.5 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.5 | 2.5 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.5 | 1.5 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.5 | 1.5 | GO:0003979 | UDP-glucose 6-dehydrogenase activity(GO:0003979) |
0.5 | 0.5 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.5 | 1.9 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.5 | 1.9 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) |
0.5 | 3.2 | GO:0019956 | chemokine binding(GO:0019956) |
0.5 | 3.2 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.5 | 1.4 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
0.5 | 2.8 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
0.5 | 0.9 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.5 | 1.4 | GO:0004473 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
0.5 | 1.8 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.5 | 3.6 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.5 | 1.4 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.5 | 1.8 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.4 | 1.3 | GO:0019002 | GMP binding(GO:0019002) |
0.4 | 1.8 | GO:0004064 | arylesterase activity(GO:0004064) |
0.4 | 3.9 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.4 | 1.3 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.4 | 2.2 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.4 | 0.9 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.4 | 11.5 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.4 | 2.5 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.4 | 2.1 | GO:1904047 | S-adenosyl-L-methionine binding(GO:1904047) |
0.4 | 4.6 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.4 | 1.2 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) |
0.4 | 0.8 | GO:0042731 | PH domain binding(GO:0042731) |
0.4 | 0.4 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.4 | 1.6 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.4 | 0.4 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.4 | 0.8 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.4 | 1.2 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.4 | 0.4 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.4 | 6.8 | GO:0015026 | coreceptor activity(GO:0015026) |
0.4 | 1.6 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.4 | 2.0 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.4 | 0.8 | GO:0031403 | lithium ion binding(GO:0031403) |
0.4 | 1.2 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
0.4 | 1.2 | GO:0070905 | serine binding(GO:0070905) |
0.4 | 1.9 | GO:0070404 | NADH binding(GO:0070404) |
0.4 | 1.2 | GO:0016015 | morphogen activity(GO:0016015) |
0.4 | 2.7 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.4 | 1.5 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.4 | 1.9 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.4 | 2.3 | GO:0001179 | RNA polymerase I transcription factor binding(GO:0001179) |
0.4 | 1.5 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
0.4 | 9.9 | GO:0045182 | translation regulator activity(GO:0045182) |
0.4 | 1.1 | GO:0086077 | gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling(GO:0086077) |
0.4 | 1.1 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
0.4 | 4.2 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.4 | 3.0 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.4 | 1.5 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.4 | 1.5 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.4 | 4.4 | GO:0051400 | BH domain binding(GO:0051400) |
0.4 | 1.5 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.4 | 0.7 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.4 | 3.3 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.4 | 2.2 | GO:1990948 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
0.4 | 1.8 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
0.4 | 5.4 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.4 | 2.1 | GO:0002135 | CTP binding(GO:0002135) |
0.4 | 1.4 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.4 | 2.5 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.4 | 4.6 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.4 | 2.5 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.4 | 1.1 | GO:0008176 | tRNA (guanine-N7-)-methyltransferase activity(GO:0008176) |
0.3 | 1.4 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.3 | 2.4 | GO:0000150 | recombinase activity(GO:0000150) |
0.3 | 1.0 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.3 | 3.1 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.3 | 1.0 | GO:0071568 | UFM1 transferase activity(GO:0071568) |
0.3 | 2.4 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.3 | 0.3 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.3 | 3.7 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.3 | 2.7 | GO:0030274 | LIM domain binding(GO:0030274) |
0.3 | 15.1 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.3 | 2.7 | GO:0031432 | titin binding(GO:0031432) |
0.3 | 1.0 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.3 | 4.6 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
0.3 | 2.6 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.3 | 2.3 | GO:0034452 | dynactin binding(GO:0034452) |
0.3 | 1.0 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.3 | 5.5 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.3 | 1.3 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.3 | 2.6 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.3 | 10.4 | GO:0005112 | Notch binding(GO:0005112) |
0.3 | 0.6 | GO:0097677 | STAT family protein binding(GO:0097677) |
0.3 | 1.0 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
0.3 | 1.3 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.3 | 5.7 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.3 | 1.6 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.3 | 0.3 | GO:0003681 | bent DNA binding(GO:0003681) |
0.3 | 4.4 | GO:0017166 | vinculin binding(GO:0017166) |
0.3 | 1.2 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
0.3 | 5.6 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.3 | 1.8 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.3 | 1.5 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.3 | 0.9 | GO:0046911 | hydroxyapatite binding(GO:0046848) metal chelating activity(GO:0046911) phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.3 | 5.4 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.3 | 2.4 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.3 | 2.4 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.3 | 2.1 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.3 | 0.9 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.3 | 2.7 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.3 | 0.6 | GO:0034711 | inhibin binding(GO:0034711) |
0.3 | 1.5 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.3 | 2.1 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.3 | 2.3 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.3 | 0.9 | GO:0004454 | ketohexokinase activity(GO:0004454) |
0.3 | 4.1 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.3 | 1.2 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.3 | 0.6 | GO:0032407 | MutSalpha complex binding(GO:0032407) |
0.3 | 1.2 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.3 | 25.1 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.3 | 0.3 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.3 | 1.4 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.3 | 3.1 | GO:0033764 | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor(GO:0033764) |
0.3 | 2.2 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.3 | 1.1 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.3 | 7.8 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.3 | 1.7 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.3 | 0.3 | GO:0070405 | quaternary ammonium group binding(GO:0050997) ammonium ion binding(GO:0070405) |
0.3 | 1.1 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.3 | 8.8 | GO:0005109 | frizzled binding(GO:0005109) |
0.3 | 0.8 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
0.3 | 1.4 | GO:0034604 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.3 | 1.1 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.3 | 3.0 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.3 | 1.1 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
0.3 | 0.8 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.3 | 1.1 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.3 | 1.1 | GO:0070976 | TIR domain binding(GO:0070976) |
0.3 | 0.8 | GO:1990269 | RNA polymerase II C-terminal domain phosphoserine binding(GO:1990269) |
0.3 | 0.8 | GO:0050700 | CARD domain binding(GO:0050700) |
0.3 | 4.7 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.3 | 0.3 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.3 | 3.6 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.3 | 0.8 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.3 | 1.8 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.3 | 0.8 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.3 | 1.3 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
0.3 | 4.8 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.3 | 1.5 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.3 | 2.5 | GO:0008430 | selenium binding(GO:0008430) |
0.3 | 3.0 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.2 | 4.7 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.2 | 3.0 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.2 | 2.0 | GO:0023023 | MHC protein complex binding(GO:0023023) |
0.2 | 2.5 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.2 | 1.2 | GO:0004954 | icosanoid receptor activity(GO:0004953) prostanoid receptor activity(GO:0004954) prostaglandin receptor activity(GO:0004955) |
0.2 | 3.4 | GO:0043495 | protein anchor(GO:0043495) |
0.2 | 1.0 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.2 | 1.5 | GO:0000298 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) |
0.2 | 1.4 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.2 | 1.0 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.2 | 0.2 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.2 | 0.5 | GO:0001639 | PLC activating G-protein coupled glutamate receptor activity(GO:0001639) G-protein coupled receptor activity involved in regulation of postsynaptic membrane potential(GO:0099530) |
0.2 | 2.9 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.2 | 1.6 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.2 | 0.5 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.2 | 2.3 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.2 | 0.7 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.2 | 1.4 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) |
0.2 | 2.9 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.2 | 0.9 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.2 | 1.8 | GO:0015643 | toxic substance binding(GO:0015643) |
0.2 | 2.9 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.2 | 1.8 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.2 | 0.9 | GO:0004359 | glutaminase activity(GO:0004359) |
0.2 | 0.2 | GO:0031762 | alpha-1A adrenergic receptor binding(GO:0031691) alpha-1B adrenergic receptor binding(GO:0031692) follicle-stimulating hormone receptor binding(GO:0031762) |
0.2 | 0.9 | GO:0034618 | arginine binding(GO:0034618) |
0.2 | 1.9 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.2 | 0.9 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.2 | 0.4 | GO:0002054 | nucleobase binding(GO:0002054) |
0.2 | 0.9 | GO:0035243 | protein-arginine omega-N symmetric methyltransferase activity(GO:0035243) |
0.2 | 0.4 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.2 | 0.8 | GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity(GO:0004066) |
0.2 | 4.2 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.2 | 1.0 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.2 | 2.7 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.2 | 6.1 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.2 | 0.6 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
0.2 | 2.3 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.2 | 0.8 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.2 | 0.8 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.2 | 1.4 | GO:0043176 | amine binding(GO:0043176) |
0.2 | 0.2 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.2 | 0.2 | GO:0009383 | rRNA (cytosine-C5-)-methyltransferase activity(GO:0009383) |
0.2 | 2.4 | GO:0008143 | poly(A) binding(GO:0008143) |
0.2 | 0.8 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.2 | 1.8 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.2 | 0.2 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
0.2 | 0.8 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.2 | 31.2 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.2 | 0.6 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.2 | 0.6 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.2 | 0.4 | GO:0044388 | small protein activating enzyme binding(GO:0044388) |
0.2 | 7.8 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.2 | 0.6 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.2 | 7.9 | GO:0097472 | cyclin-dependent protein kinase activity(GO:0097472) |
0.2 | 16.0 | GO:0001047 | core promoter binding(GO:0001047) |
0.2 | 1.2 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.2 | 2.9 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.2 | 0.6 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.2 | 0.6 | GO:0070736 | protein-glycine ligase activity(GO:0070735) protein-glycine ligase activity, initiating(GO:0070736) |
0.2 | 1.0 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.2 | 2.3 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.2 | 2.1 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.2 | 0.8 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.2 | 0.2 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.2 | 0.4 | GO:0004568 | chitinase activity(GO:0004568) |
0.2 | 11.5 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.2 | 15.7 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.2 | 0.9 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
0.2 | 0.6 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.2 | 2.8 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.2 | 13.6 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.2 | 1.1 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.2 | 1.8 | GO:0008227 | G-protein coupled amine receptor activity(GO:0008227) |
0.2 | 0.5 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.2 | 1.9 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.2 | 1.4 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.2 | 2.3 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.2 | 1.7 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.2 | 0.3 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.2 | 2.2 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.2 | 1.0 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.2 | 0.7 | GO:0032356 | oxidized DNA binding(GO:0032356) |
0.2 | 0.5 | GO:0005171 | hepatocyte growth factor receptor binding(GO:0005171) |
0.2 | 12.6 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.2 | 1.0 | GO:0031419 | cobalamin binding(GO:0031419) |
0.2 | 1.2 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.2 | 4.3 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.2 | 1.5 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.2 | 1.3 | GO:0055103 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.2 | 3.7 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
0.2 | 1.0 | GO:0071949 | FAD binding(GO:0071949) |
0.2 | 7.6 | GO:0061650 | ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.2 | 0.2 | GO:0008948 | oxaloacetate decarboxylase activity(GO:0008948) |
0.2 | 0.5 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.2 | 1.3 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
0.2 | 0.3 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.2 | 1.0 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.2 | 2.1 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.2 | 1.8 | GO:0019531 | secondary active sulfate transmembrane transporter activity(GO:0008271) oxalate transmembrane transporter activity(GO:0019531) |
0.2 | 1.4 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.2 | 4.0 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
0.2 | 1.3 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.2 | 3.2 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.2 | 0.2 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.2 | 0.3 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.2 | 1.7 | GO:0070628 | proteasome binding(GO:0070628) |
0.2 | 0.8 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.2 | 0.3 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.2 | 1.1 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.2 | 3.0 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.2 | 0.5 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.2 | 0.8 | GO:0009055 | electron carrier activity(GO:0009055) |
0.2 | 1.2 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.2 | 0.9 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.2 | 1.4 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.2 | 1.7 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
0.2 | 1.4 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.2 | 1.2 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.2 | 2.3 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.2 | 1.1 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.1 | 8.4 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.1 | 0.4 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.1 | 0.6 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.1 | 3.7 | GO:0005179 | hormone activity(GO:0005179) |
0.1 | 4.5 | GO:0019213 | deacetylase activity(GO:0019213) |
0.1 | 3.2 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 27.4 | GO:0042393 | histone binding(GO:0042393) |
0.1 | 0.1 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.1 | 2.0 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 0.4 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.1 | 0.6 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.1 | 0.8 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.1 | 1.3 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.1 | 0.4 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.1 | 0.8 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.1 | 2.1 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.1 | 0.7 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.1 | 0.1 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.1 | 0.1 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.1 | 1.9 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.1 | 0.1 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.1 | 2.4 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.1 | 0.3 | GO:0016428 | tRNA (cytosine) methyltransferase activity(GO:0016427) tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.1 | 0.9 | GO:1901612 | phosphatidylglycerol binding(GO:1901611) cardiolipin binding(GO:1901612) |
0.1 | 0.4 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.1 | 0.3 | GO:0015265 | urea channel activity(GO:0015265) |
0.1 | 4.6 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 0.5 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
0.1 | 1.9 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.1 | 0.4 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.1 | 0.8 | GO:0070840 | dynein complex binding(GO:0070840) |
0.1 | 0.9 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.1 | 0.3 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.1 | 0.4 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.1 | 0.4 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.1 | 0.4 | GO:0047256 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
0.1 | 0.2 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.1 | 1.0 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.1 | 0.5 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.1 | 5.0 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.1 | 0.4 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
0.1 | 0.4 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.1 | 0.4 | GO:0051425 | PTB domain binding(GO:0051425) |
0.1 | 0.5 | GO:0097003 | adiponectin binding(GO:0055100) adipokinetic hormone receptor activity(GO:0097003) |
0.1 | 2.3 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.1 | 0.7 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 0.8 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 0.5 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.1 | 2.3 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 1.9 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.1 | 0.4 | GO:0004103 | choline kinase activity(GO:0004103) |
0.1 | 0.7 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.1 | 0.2 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.1 | 1.2 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.1 | 0.3 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.1 | 0.9 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.1 | 1.2 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.1 | 1.0 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.2 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.1 | 1.7 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.1 | 0.4 | GO:0016675 | oxidoreductase activity, acting on a heme group of donors(GO:0016675) |
0.1 | 0.4 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.1 | 0.3 | GO:0004660 | protein farnesyltransferase activity(GO:0004660) |
0.1 | 1.8 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.1 | 0.4 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 0.9 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.1 | 0.4 | GO:0016936 | galactoside binding(GO:0016936) |
0.1 | 0.3 | GO:0016918 | retinal binding(GO:0016918) |
0.1 | 0.5 | GO:1990188 | euchromatin binding(GO:1990188) |
0.1 | 0.7 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.1 | 2.1 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 1.1 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.1 | 0.2 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.1 | 0.5 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.1 | 0.8 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.1 | 1.0 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.1 | 0.7 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 0.3 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.1 | 0.4 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 0.3 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.1 | 1.2 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 0.3 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.1 | 0.1 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.1 | 0.3 | GO:0061711 | N(6)-L-threonylcarbamoyladenine synthase(GO:0061711) |
0.1 | 0.2 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.1 | 3.4 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.1 | 0.4 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.1 | 0.3 | GO:0005025 | transforming growth factor beta-activated receptor activity(GO:0005024) transforming growth factor beta receptor activity, type I(GO:0005025) |
0.1 | 2.8 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.1 | 0.6 | GO:0015266 | protein channel activity(GO:0015266) |
0.1 | 0.5 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.1 | 1.0 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.1 | 0.1 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
0.1 | 0.7 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.1 | 1.0 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 0.3 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.1 | 0.5 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.1 | 1.5 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.1 | 2.6 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 1.0 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.1 | 0.2 | GO:0051747 | cytosine C-5 DNA demethylase activity(GO:0051747) |
0.1 | 0.9 | GO:0001848 | complement binding(GO:0001848) |
0.1 | 21.7 | GO:0003682 | chromatin binding(GO:0003682) |
0.1 | 0.7 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) serine-type exopeptidase activity(GO:0070008) |
0.1 | 0.4 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.1 | 2.6 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.1 | 0.4 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 0.2 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.1 | 0.3 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.1 | 1.2 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.1 | 0.4 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.1 | 0.2 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) |
0.1 | 0.1 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.1 | 0.1 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.1 | 0.4 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 1.4 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 0.8 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.1 | 0.8 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.1 | 0.2 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.1 | 1.6 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.1 | 0.4 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.1 | 1.8 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.1 | 0.9 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.1 | 0.8 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.1 | 0.9 | GO:0051861 | glycolipid binding(GO:0051861) |
0.1 | 0.2 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.1 | 0.1 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.1 | 0.6 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.1 | 0.6 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.1 | 0.1 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.1 | 0.5 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.1 | 0.2 | GO:0016894 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters(GO:0016894) |
0.1 | 0.6 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 1.5 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 1.0 | GO:0005504 | fatty acid binding(GO:0005504) |
0.1 | 1.4 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.1 | 1.3 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.1 | 0.2 | GO:0003998 | acylphosphatase activity(GO:0003998) |
0.1 | 0.3 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 0.5 | GO:0098811 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.1 | 27.7 | GO:0043565 | sequence-specific DNA binding(GO:0043565) |
0.1 | 1.1 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.1 | 0.3 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.1 | 0.1 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.1 | 2.8 | GO:0004004 | RNA helicase activity(GO:0003724) ATP-dependent RNA helicase activity(GO:0004004) |
0.0 | 0.1 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.0 | 2.6 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 0.8 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.0 | 0.6 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.0 | 0.5 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.0 | 0.3 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.0 | 0.1 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.0 | 0.6 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.0 | 0.2 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.0 | 0.1 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
0.0 | 0.4 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.3 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.0 | 0.1 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.0 | 0.2 | GO:0019808 | polyamine binding(GO:0019808) |
0.0 | 0.1 | GO:0003977 | UDP-N-acetylglucosamine diphosphorylase activity(GO:0003977) |
0.0 | 0.7 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.0 | 0.1 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.0 | 0.7 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.0 | 0.2 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.0 | 0.2 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.0 | 0.1 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) DNA polymerase activity(GO:0034061) |
0.0 | 0.1 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) enone reductase activity(GO:0035671) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.0 | 0.9 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.9 | GO:0000049 | tRNA binding(GO:0000049) |
0.0 | 0.1 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
0.0 | 0.1 | GO:0032558 | adenyl deoxyribonucleotide binding(GO:0032558) |
0.0 | 0.1 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) |
0.0 | 0.1 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.0 | 0.1 | GO:0033691 | sialic acid binding(GO:0033691) |
0.0 | 0.4 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.0 | 0.1 | GO:0015288 | porin activity(GO:0015288) |
0.0 | 0.1 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.0 | 0.8 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.0 | 0.1 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
0.0 | 0.1 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.0 | 0.1 | GO:0004482 | mRNA (guanine-N7-)-methyltransferase activity(GO:0004482) |
0.0 | 0.1 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.0 | 0.1 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.0 | 1.8 | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding(GO:0000981) |
0.0 | 0.2 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.0 | 1.4 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.0 | 0.5 | GO:0016289 | CoA hydrolase activity(GO:0016289) |
0.0 | 0.2 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.0 | 0.0 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.0 | 0.2 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.0 | 0.0 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.0 | 0.1 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.0 | 0.6 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 0.1 | GO:0008802 | betaine-aldehyde dehydrogenase activity(GO:0008802) |
0.0 | 0.0 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) sodium:inorganic phosphate symporter activity(GO:0015319) |
0.0 | 0.0 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.0 | 0.3 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.0 | 0.2 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.0 | 0.0 | GO:0070728 | leucine binding(GO:0070728) |
0.0 | 0.1 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.0 | 0.1 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.0 | 0.1 | GO:0044548 | S100 protein binding(GO:0044548) |
0.0 | 0.1 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.0 | 0.0 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.0 | 0.2 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.0 | 0.1 | GO:0052654 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
0.0 | 0.2 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.0 | 8.6 | GO:0003723 | RNA binding(GO:0003723) |
Gene overrepresentation in C2:CP category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 24.9 | SA_REG_CASCADE_OF_CYCLIN_EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.9 | 0.9 | PID_AMB2_NEUTROPHILS_PATHWAY | amb2 Integrin signaling |
0.8 | 37.7 | PID_AURORA_B_PATHWAY | Aurora B signaling |
0.6 | 1.3 | PID_S1P_S1P3_PATHWAY | S1P3 pathway |
0.6 | 19.4 | PID_WNT_SIGNALING_PATHWAY | Wnt signaling network |
0.6 | 31.0 | PID_PLK1_PATHWAY | PLK1 signaling events |
0.5 | 1.6 | PID_EPHA2_FWD_PATHWAY | EPHA2 forward signaling |
0.4 | 13.7 | PID_SYNDECAN_4_PATHWAY | Syndecan-4-mediated signaling events |
0.4 | 31.0 | PID_E2F_PATHWAY | E2F transcription factor network |
0.4 | 17.1 | NABA_COLLAGENS | Genes encoding collagen proteins |
0.4 | 4.9 | PID_INTEGRIN5_PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.3 | 30.5 | PID_SMAD2_3NUCLEAR_PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.3 | 32.6 | PID_MYC_ACTIV_PATHWAY | Validated targets of C-MYC transcriptional activation |
0.3 | 7.4 | PID_SMAD2_3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.3 | 4.0 | PID_VEGF_VEGFR_PATHWAY | VEGF and VEGFR signaling network |
0.3 | 2.6 | SA_B_CELL_RECEPTOR_COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.3 | 0.7 | ST_STAT3_PATHWAY | STAT3 Pathway |
0.3 | 0.3 | PID_IGF1_PATHWAY | IGF1 pathway |
0.3 | 7.1 | PID_HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.3 | 5.3 | PID_EPHRINB_REV_PATHWAY | Ephrin B reverse signaling |
0.3 | 5.0 | PID_BARD1_PATHWAY | BARD1 signaling events |
0.3 | 1.2 | PID_THROMBIN_PAR1_PATHWAY | PAR1-mediated thrombin signaling events |
0.3 | 5.8 | PID_HIF1A_PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.3 | 12.3 | PID_HES_HEY_PATHWAY | Notch-mediated HES/HEY network |
0.3 | 12.3 | PID_FANCONI_PATHWAY | Fanconi anemia pathway |
0.3 | 0.6 | SA_FAS_SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.3 | 5.2 | PID_FOXM1_PATHWAY | FOXM1 transcription factor network |
0.3 | 1.1 | PID_ALK2_PATHWAY | ALK2 signaling events |
0.3 | 8.5 | PID_HNF3B_PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.3 | 0.3 | SA_TRKA_RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.3 | 8.3 | PID_DELTA_NP63_PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.3 | 10.3 | PID_BMP_PATHWAY | BMP receptor signaling |
0.2 | 4.5 | PID_PRL_SIGNALING_EVENTS_PATHWAY | Signaling events mediated by PRL |
0.2 | 1.4 | PID_VEGFR1_PATHWAY | VEGFR1 specific signals |
0.2 | 0.7 | PID_AR_NONGENOMIC_PATHWAY | Nongenotropic Androgen signaling |
0.2 | 1.1 | PID_EPO_PATHWAY | EPO signaling pathway |
0.2 | 4.5 | PID_HEDGEHOG_2PATHWAY | Signaling events mediated by the Hedgehog family |
0.2 | 10.7 | PID_MYC_REPRESS_PATHWAY | Validated targets of C-MYC transcriptional repression |
0.2 | 9.0 | PID_ILK_PATHWAY | Integrin-linked kinase signaling |
0.2 | 0.8 | PID_TCR_RAS_PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.2 | 0.4 | SIG_BCR_SIGNALING_PATHWAY | Members of the BCR signaling pathway |
0.2 | 4.1 | PID_FAK_PATHWAY | Signaling events mediated by focal adhesion kinase |
0.2 | 12.5 | PID_AR_PATHWAY | Coregulation of Androgen receptor activity |
0.2 | 5.8 | PID_IL4_2PATHWAY | IL4-mediated signaling events |
0.2 | 10.9 | PID_FGF_PATHWAY | FGF signaling pathway |
0.2 | 6.8 | ST_P38_MAPK_PATHWAY | p38 MAPK Pathway |
0.2 | 0.6 | PID_MYC_PATHWAY | C-MYC pathway |
0.2 | 2.7 | PID_GLYPICAN_1PATHWAY | Glypican 1 network |
0.2 | 3.8 | PID_RET_PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.2 | 3.2 | PID_ATR_PATHWAY | ATR signaling pathway |
0.2 | 9.2 | PID_NOTCH_PATHWAY | Notch signaling pathway |
0.2 | 0.7 | PID_ERB_GENOMIC_PATHWAY | Validated nuclear estrogen receptor beta network |
0.2 | 3.4 | PID_ALK1_PATHWAY | ALK1 signaling events |
0.2 | 3.2 | ST_ERK1_ERK2_MAPK_PATHWAY | ERK1/ERK2 MAPK Pathway |
0.2 | 7.4 | PID_AP1_PATHWAY | AP-1 transcription factor network |
0.2 | 0.9 | PID_TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.2 | 1.4 | PID_HDAC_CLASSIII_PATHWAY | Signaling events mediated by HDAC Class III |
0.2 | 4.5 | PID_RETINOIC_ACID_PATHWAY | Retinoic acid receptors-mediated signaling |
0.2 | 0.2 | NABA_BASEMENT_MEMBRANES | Genes encoding structural components of basement membranes |
0.2 | 0.8 | PID_PDGFRA_PATHWAY | PDGFR-alpha signaling pathway |
0.2 | 0.3 | PID_IL8_CXCR1_PATHWAY | IL8- and CXCR1-mediated signaling events |
0.2 | 0.2 | PID_LYMPH_ANGIOGENESIS_PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.2 | 1.4 | PID_BETA_CATENIN_DEG_PATHWAY | Degradation of beta catenin |
0.2 | 1.4 | PID_INTEGRIN2_PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 7.4 | PID_ERA_GENOMIC_PATHWAY | Validated nuclear estrogen receptor alpha network |
0.1 | 0.9 | PID_NEPHRIN_NEPH1_PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 3.9 | PID_NECTIN_PATHWAY | Nectin adhesion pathway |
0.1 | 1.1 | PID_ERBB_NETWORK_PATHWAY | ErbB receptor signaling network |
0.1 | 0.4 | ST_ADRENERGIC | Adrenergic Pathway |
0.1 | 1.6 | ST_T_CELL_SIGNAL_TRANSDUCTION | T Cell Signal Transduction |
0.1 | 4.9 | PID_TAP63_PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 2.7 | PID_INTEGRIN1_PATHWAY | Beta1 integrin cell surface interactions |
0.1 | 14.8 | NABA_ECM_GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 1.2 | PID_P38_MK2_PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 3.2 | PID_HIF1_TFPATHWAY | HIF-1-alpha transcription factor network |
0.1 | 0.8 | PID_TNF_PATHWAY | TNF receptor signaling pathway |
0.1 | 2.1 | PID_TCR_CALCIUM_PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.1 | 0.2 | PID_NFKAPPAB_ATYPICAL_PATHWAY | Atypical NF-kappaB pathway |
0.1 | 1.7 | PID_ALPHA_SYNUCLEIN_PATHWAY | Alpha-synuclein signaling |
0.1 | 0.5 | PID_TCR_JNK_PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.1 | 1.0 | PID_TCPTP_PATHWAY | Signaling events mediated by TCPTP |
0.1 | 1.5 | PID_PS1_PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 1.2 | PID_IL12_STAT4_PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 0.7 | PID_TRAIL_PATHWAY | TRAIL signaling pathway |
0.1 | 2.2 | PID_HEDGEHOG_GLI_PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.1 | 1.2 | PID_AURORA_A_PATHWAY | Aurora A signaling |
0.1 | 0.1 | PID_IL8_CXCR2_PATHWAY | IL8- and CXCR2-mediated signaling events |
0.1 | 0.9 | PID_FCER1_PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 2.7 | PID_CMYB_PATHWAY | C-MYB transcription factor network |
0.1 | 0.3 | PID_SYNDECAN_2_PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 0.3 | PID_FRA_PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 2.3 | PID_HDAC_CLASSI_PATHWAY | Signaling events mediated by HDAC Class I |
0.1 | 1.5 | PID_CERAMIDE_PATHWAY | Ceramide signaling pathway |
0.1 | 0.4 | PID_WNT_NONCANONICAL_PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 0.3 | PID_WNT_CANONICAL_PATHWAY | Canonical Wnt signaling pathway |
0.1 | 0.4 | PID_INTEGRIN_A9B1_PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 0.8 | PID_NFAT_TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 0.8 | PID_ATM_PATHWAY | ATM pathway |
0.0 | 0.9 | PID_TOLL_ENDOGENOUS_PATHWAY | Endogenous TLR signaling |
0.0 | 0.7 | PID_NETRIN_PATHWAY | Netrin-mediated signaling events |
0.0 | 0.4 | ST_G_ALPHA_S_PATHWAY | G alpha s Pathway |
0.0 | 0.1 | PID_FAS_PATHWAY | FAS (CD95) signaling pathway |
0.0 | 0.2 | PID_A6B1_A6B4_INTEGRIN_PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 0.5 | ST_G_ALPHA_I_PATHWAY | G alpha i Pathway |
0.0 | 0.5 | SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES | Genes related to the insulin receptor pathway |
0.0 | 0.5 | PID_IL12_2PATHWAY | IL12-mediated signaling events |
0.0 | 0.3 | SIG_CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 0.5 | PID_INSULIN_GLUCOSE_PATHWAY | Insulin-mediated glucose transport |
0.0 | 0.0 | PID_IL23_PATHWAY | IL23-mediated signaling events |
0.0 | 0.5 | PID_P53_REGULATION_PATHWAY | p53 pathway |
0.0 | 0.1 | PID_CONE_PATHWAY | Visual signal transduction: Cones |
0.0 | 0.3 | PID_TELOMERASE_PATHWAY | Regulation of Telomerase |
0.0 | 0.4 | PID_P73PATHWAY | p73 transcription factor network |
Gene overrepresentation in C2:CP:REACTOME category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 2.5 | REACTOME_CDC6_ASSOCIATION_WITH_THE_ORC_ORIGIN_COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
1.2 | 11.0 | REACTOME_SIGNALING_BY_FGFR3_MUTANTS | Genes involved in Signaling by FGFR3 mutants |
1.2 | 16.5 | REACTOME_RECEPTOR_LIGAND_BINDING_INITIATES_THE_SECOND_PROTEOLYTIC_CLEAVAGE_OF_NOTCH_RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
1.2 | 23.4 | REACTOME_G1_S_SPECIFIC_TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
1.1 | 3.4 | REACTOME_FGFR2C_LIGAND_BINDING_AND_ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
1.1 | 9.1 | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
1.0 | 7.7 | REACTOME_APOBEC3G_MEDIATED_RESISTANCE_TO_HIV1_INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.9 | 0.9 | REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.8 | 0.8 | REACTOME_MRNA_DECAY_BY_3_TO_5_EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.8 | 24.5 | REACTOME_YAP1_AND_WWTR1_TAZ_STIMULATED_GENE_EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.7 | 10.5 | REACTOME_REPAIR_SYNTHESIS_FOR_GAP_FILLING_BY_DNA_POL_IN_TC_NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.7 | 4.1 | REACTOME_PROCESSIVE_SYNTHESIS_ON_THE_LAGGING_STRAND | Genes involved in Processive synthesis on the lagging strand |
0.7 | 9.7 | REACTOME_CHYLOMICRON_MEDIATED_LIPID_TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.7 | 36.9 | REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.6 | 5.8 | REACTOME_BILE_SALT_AND_ORGANIC_ANION_SLC_TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.6 | 8.7 | REACTOME_ACTIVATION_OF_THE_PRE_REPLICATIVE_COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.6 | 9.9 | REACTOME_G0_AND_EARLY_G1 | Genes involved in G0 and Early G1 |
0.6 | 15.2 | REACTOME_STRIATED_MUSCLE_CONTRACTION | Genes involved in Striated Muscle Contraction |
0.6 | 24.5 | REACTOME_GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.6 | 15.5 | REACTOME_KINESINS | Genes involved in Kinesins |
0.6 | 9.5 | REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.5 | 3.8 | REACTOME_E2F_ENABLED_INHIBITION_OF_PRE_REPLICATION_COMPLEX_FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.5 | 15.9 | REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.5 | 2.1 | REACTOME_ETHANOL_OXIDATION | Genes involved in Ethanol oxidation |
0.5 | 9.8 | REACTOME_PRE_NOTCH_TRANSCRIPTION_AND_TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.5 | 1.0 | REACTOME_CROSS_PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.5 | 1.9 | REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_ | Genes involved in Cleavage of Growing Transcript in the Termination Region |
0.4 | 0.8 | REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.4 | 7.5 | REACTOME_OXYGEN_DEPENDENT_PROLINE_HYDROXYLATION_OF_HYPOXIA_INDUCIBLE_FACTOR_ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.4 | 4.5 | REACTOME_BASE_FREE_SUGAR_PHOSPHATE_REMOVAL_VIA_THE_SINGLE_NUCLEOTIDE_REPLACEMENT_PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.4 | 0.8 | REACTOME_ACTIVATED_POINT_MUTANTS_OF_FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.4 | 4.8 | REACTOME_CYCLIN_A_B1_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.4 | 4.2 | REACTOME_SIGNAL_ATTENUATION | Genes involved in Signal attenuation |
0.4 | 2.2 | REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.4 | 7.2 | REACTOME_DESTABILIZATION_OF_MRNA_BY_BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.3 | 0.7 | REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PLC_BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.3 | 5.9 | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.3 | 2.4 | REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.3 | 1.4 | REACTOME_SPRY_REGULATION_OF_FGF_SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.3 | 28.6 | REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.3 | 6.8 | REACTOME_INHIBITION_OF_THE_PROTEOLYTIC_ACTIVITY_OF_APC_C_REQUIRED_FOR_THE_ONSET_OF_ANAPHASE_BY_MITOTIC_SPINDLE_CHECKPOINT_COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.3 | 7.5 | REACTOME_G1_PHASE | Genes involved in G1 Phase |
0.3 | 4.0 | REACTOME_VEGF_LIGAND_RECEPTOR_INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.3 | 6.9 | REACTOME_RNA_POL_I_PROMOTER_OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.3 | 5.9 | REACTOME_MEIOTIC_RECOMBINATION | Genes involved in Meiotic Recombination |
0.3 | 1.2 | REACTOME_REGULATION_OF_INSULIN_SECRETION_BY_ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.3 | 1.2 | REACTOME_HOMOLOGOUS_RECOMBINATION_REPAIR_OF_REPLICATION_INDEPENDENT_DOUBLE_STRAND_BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.3 | 6.3 | REACTOME_FANCONI_ANEMIA_PATHWAY | Genes involved in Fanconi Anemia pathway |
0.3 | 3.3 | REACTOME_SIGNALING_BY_NODAL | Genes involved in Signaling by NODAL |
0.3 | 7.4 | REACTOME_RNA_POL_I_TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.3 | 5.8 | REACTOME_PYRIMIDINE_METABOLISM | Genes involved in Pyrimidine metabolism |
0.3 | 1.1 | REACTOME_ADP_SIGNALLING_THROUGH_P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.3 | 23.0 | REACTOME_MITOTIC_PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.3 | 0.3 | REACTOME_REGULATION_OF_AMPK_ACTIVITY_VIA_LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.3 | 2.4 | REACTOME_GLUCURONIDATION | Genes involved in Glucuronidation |
0.3 | 0.3 | REACTOME_REGULATED_PROTEOLYSIS_OF_P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.3 | 5.7 | REACTOME_PTM_GAMMA_CARBOXYLATION_HYPUSINE_FORMATION_AND_ARYLSULFATASE_ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.3 | 0.5 | REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_SINGLE_NUCLEOTIDE_REPLACEMENT_PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.3 | 2.0 | REACTOME_RAF_MAP_KINASE_CASCADE | Genes involved in RAF/MAP kinase cascade |
0.3 | 21.8 | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.2 | 1.7 | REACTOME_EXTENSION_OF_TELOMERES | Genes involved in Extension of Telomeres |
0.2 | 1.2 | REACTOME_PACKAGING_OF_TELOMERE_ENDS | Genes involved in Packaging Of Telomere Ends |
0.2 | 0.7 | REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.2 | 2.4 | REACTOME_AMYLOIDS | Genes involved in Amyloids |
0.2 | 28.8 | REACTOME_INFLUENZA_VIRAL_RNA_TRANSCRIPTION_AND_REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.2 | 4.8 | REACTOME_CITRIC_ACID_CYCLE_TCA_CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.2 | 2.2 | REACTOME_HYALURONAN_UPTAKE_AND_DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.2 | 1.5 | REACTOME_AQUAPORIN_MEDIATED_TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.2 | 3.9 | REACTOME_FORMATION_OF_ATP_BY_CHEMIOSMOTIC_COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.2 | 2.1 | REACTOME_HDL_MEDIATED_LIPID_TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.2 | 5.1 | REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.2 | 2.9 | REACTOME_REGULATION_OF_KIT_SIGNALING | Genes involved in Regulation of KIT signaling |
0.2 | 0.2 | REACTOME_PROSTACYCLIN_SIGNALLING_THROUGH_PROSTACYCLIN_RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.2 | 2.1 | REACTOME_FACILITATIVE_NA_INDEPENDENT_GLUCOSE_TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.2 | 0.4 | REACTOME_G_PROTEIN_ACTIVATION | Genes involved in G-protein activation |
0.2 | 2.5 | REACTOME_AMINE_LIGAND_BINDING_RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.2 | 0.2 | REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.2 | 23.6 | REACTOME_MRNA_SPLICING | Genes involved in mRNA Splicing |
0.2 | 1.1 | REACTOME_TETRAHYDROBIOPTERIN_BH4_SYNTHESIS_RECYCLING_SALVAGE_AND_REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.2 | 1.3 | REACTOME_FORMATION_OF_FIBRIN_CLOT_CLOTTING_CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.2 | 0.4 | REACTOME_RETROGRADE_NEUROTROPHIN_SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.2 | 4.1 | REACTOME_SULFUR_AMINO_ACID_METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.2 | 0.5 | REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.2 | 0.9 | REACTOME_SHC1_EVENTS_IN_ERBB4_SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.2 | 2.0 | REACTOME_ADVANCED_GLYCOSYLATION_ENDPRODUCT_RECEPTOR_SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.2 | 10.1 | REACTOME_DESTABILIZATION_OF_MRNA_BY_AUF1_HNRNP_D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.2 | 2.4 | REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.2 | 1.4 | REACTOME_TRYPTOPHAN_CATABOLISM | Genes involved in Tryptophan catabolism |
0.2 | 2.5 | REACTOME_SYNTHESIS_SECRETION_AND_DEACYLATION_OF_GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.2 | 9.8 | REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.2 | 1.7 | REACTOME_ACTIVATION_OF_IRF3_IRF7_MEDIATED_BY_TBK1_IKK_EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.1 | 0.9 | REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION_IN_TLR7_8_OR_9_SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.1 | 3.5 | REACTOME_SYNTHESIS_OF_PC | Genes involved in Synthesis of PC |
0.1 | 0.9 | REACTOME_TRANSLOCATION_OF_ZAP_70_TO_IMMUNOLOGICAL_SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.1 | 0.6 | REACTOME_THROMBIN_SIGNALLING_THROUGH_PROTEINASE_ACTIVATED_RECEPTORS_PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.1 | 4.8 | REACTOME_GLUCOSE_METABOLISM | Genes involved in Glucose metabolism |
0.1 | 2.2 | REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_ACTIVITY_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 8.4 | REACTOME_LOSS_OF_NLP_FROM_MITOTIC_CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.1 | 0.7 | REACTOME_SIGNALING_BY_WNT | Genes involved in Signaling by Wnt |
0.1 | 2.1 | REACTOME_PURINE_SALVAGE | Genes involved in Purine salvage |
0.1 | 2.3 | REACTOME_ACTIVATION_OF_KAINATE_RECEPTORS_UPON_GLUTAMATE_BINDING | Genes involved in Activation of Kainate Receptors upon glutamate binding |
0.1 | 1.9 | REACTOME_DEADENYLATION_OF_MRNA | Genes involved in Deadenylation of mRNA |
0.1 | 1.4 | REACTOME_MRNA_DECAY_BY_5_TO_3_EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.1 | 1.0 | REACTOME_REGULATORY_RNA_PATHWAYS | Genes involved in Regulatory RNA pathways |
0.1 | 7.1 | REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_ | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 1.6 | REACTOME_ENOS_ACTIVATION_AND_REGULATION | Genes involved in eNOS activation and regulation |
0.1 | 0.5 | REACTOME_PEPTIDE_CHAIN_ELONGATION | Genes involved in Peptide chain elongation |
0.1 | 7.9 | REACTOME_RESPIRATORY_ELECTRON_TRANSPORT | Genes involved in Respiratory electron transport |
0.1 | 3.9 | REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 4.8 | REACTOME_MITOCHONDRIAL_PROTEIN_IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 2.2 | REACTOME_RNA_POL_II_TRANSCRIPTION_PRE_INITIATION_AND_PROMOTER_OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.1 | 0.8 | REACTOME_CD28_DEPENDENT_VAV1_PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.1 | 5.4 | REACTOME_COLLAGEN_FORMATION | Genes involved in Collagen formation |
0.1 | 0.3 | REACTOME_RORA_ACTIVATES_CIRCADIAN_EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.1 | 2.6 | REACTOME_CHOLESTEROL_BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 0.3 | REACTOME_HORMONE_LIGAND_BINDING_RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.1 | 3.4 | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.1 | 0.7 | REACTOME_FORMATION_OF_RNA_POL_II_ELONGATION_COMPLEX_ | Genes involved in Formation of RNA Pol II elongation complex |
0.1 | 0.8 | REACTOME_APOPTOSIS_INDUCED_DNA_FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.1 | 0.6 | REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 0.1 | REACTOME_IKK_COMPLEX_RECRUITMENT_MEDIATED_BY_RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.1 | 1.4 | REACTOME_AMINE_COMPOUND_SLC_TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.1 | 3.0 | REACTOME_METABOLISM_OF_NON_CODING_RNA | Genes involved in Metabolism of non-coding RNA |
0.1 | 0.4 | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
0.1 | 0.6 | REACTOME_PRESYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.1 | 1.7 | REACTOME_METABOLISM_OF_PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.1 | 1.0 | REACTOME_PURINE_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 1.7 | REACTOME_TRANSFERRIN_ENDOCYTOSIS_AND_RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.1 | 2.3 | REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.1 | 0.7 | REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES | Genes involved in Generation of second messenger molecules |
0.1 | 1.4 | REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.1 | 0.8 | REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.1 | 0.5 | REACTOME_PASSIVE_TRANSPORT_BY_AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.1 | 0.8 | REACTOME_N_GLYCAN_TRIMMING_IN_THE_ER_AND_CALNEXIN_CALRETICULIN_CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.1 | 0.5 | REACTOME_KERATAN_SULFATE_DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 0.9 | REACTOME_MUSCLE_CONTRACTION | Genes involved in Muscle contraction |
0.1 | 1.4 | REACTOME_GLYCOSPHINGOLIPID_METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 0.6 | REACTOME_ACYL_CHAIN_REMODELLING_OF_PG | Genes involved in Acyl chain remodelling of PG |
0.1 | 0.7 | REACTOME_TRAF6_MEDIATED_NFKB_ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.1 | 0.4 | REACTOME_TRANSPORT_OF_ORGANIC_ANIONS | Genes involved in Transport of organic anions |
0.1 | 2.3 | REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 1.1 | REACTOME_GLUTATHIONE_CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 0.1 | REACTOME_SIGNALLING_TO_P38_VIA_RIT_AND_RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.0 | 0.0 | REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.0 | 0.4 | REACTOME_METABOLISM_OF_POLYAMINES | Genes involved in Metabolism of polyamines |
0.0 | 1.0 | REACTOME_AMINO_ACID_SYNTHESIS_AND_INTERCONVERSION_TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.0 | 1.0 | REACTOME_SIGNALING_BY_BMP | Genes involved in Signaling by BMP |
0.0 | 2.6 | REACTOME_TRANSLATION | Genes involved in Translation |
0.0 | 1.2 | REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 0.1 | REACTOME_P53_DEPENDENT_G1_DNA_DAMAGE_RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.0 | 0.4 | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.0 | 6.5 | REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.0 | 1.1 | REACTOME_PREFOLDIN_MEDIATED_TRANSFER_OF_SUBSTRATE_TO_CCT_TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.0 | 0.1 | REACTOME_CELL_CYCLE_CHECKPOINTS | Genes involved in Cell Cycle Checkpoints |
0.0 | 0.5 | REACTOME_PYRUVATE_METABOLISM | Genes involved in Pyruvate metabolism |
0.0 | 0.8 | REACTOME_MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.3 | REACTOME_NEGATIVE_REGULATORS_OF_RIG_I_MDA5_SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.0 | 0.8 | REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.0 | 0.1 | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.0 | 0.1 | REACTOME_ANDROGEN_BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.0 | 0.2 | REACTOME_PURINE_CATABOLISM | Genes involved in Purine catabolism |
0.0 | 0.1 | REACTOME_DESTABILIZATION_OF_MRNA_BY_KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.0 | 1.1 | REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.1 | REACTOME_RNA_POL_III_TRANSCRIPTION_TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.0 | 0.2 | REACTOME_GAP_JUNCTION_ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 0.3 | REACTOME_HS_GAG_DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 0.3 | REACTOME_RNA_POL_III_TRANSCRIPTION_INITIATION_FROM_TYPE_3_PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.0 | 0.1 | REACTOME_HYALURONAN_METABOLISM | Genes involved in Hyaluronan metabolism |
0.0 | 0.1 | REACTOME_RAP1_SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 0.3 | REACTOME_SIGNALING_BY_HIPPO | Genes involved in Signaling by Hippo |